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 Introduction 
1. Introduction 
1.1 The Liver 
 
The liver is the largest internal organ in vertebrates. The earliest knowledge of 
liver anatomy dates back to approximately 2000 B.C. attributed to the Babylonians in 
the Assyro-Babylonian era (Townsend and Sabiston 2001). Thereafter, the ancient 
Greeks described for the first time the liver’s ability to regenerate in the myth of 
Prometheus. Medical terms related to the liver often start in hepato- or hepatic from 
the Greek word for liver, hēpar (ηπαρ).  
 
1.1.1 Physiology and function of the liver 
 
The liver exerts many functions including metabolism, production, storage and 
redistribution of nutrients, carbohydrates, lipids or fatty substances, and vitamins. In 
the first line, the liver serves as a central regulator of metabolic homeostasis for the 
body. It converts glucose into glycogen and stores it until required by the organism. 
The liver synthesizes plasma proteins such as clotting factors regulating blood clotting 
and albumin transferring water-insoluble substances and maintaining osmotic 
pressure. The metabolism and storage of many vitamins including vitamins A, D, K 
and B12 is another major function of the liver, which provides critical cofactors in 
enzymatic processes. Additionally, the liver produces bile acids which are essential for 
the processing of dietary fat. Other essential roles of the liver include detoxification of 
drugs, alcohol and xenobiotics, iron metabolism, clearance of by-products of 
metabolism such as bilirubin and elimination of numerous foreign antigens and 
microbes from the gut (Arias et al. 2009; Dufour and Clavien 2010). 
 
1.1.2 Hepatocytes 
 
To accomplish all these functions, distinct types of cells contribute to structure 
formation of the liver as a functional tissue. Among them, the hepatocyte, also called 
liver parenchymal cell, is the most abundant cell type by mass and number in the liver 
constituting approximately 60% of all liver cells and over 80% of the liver-cell mass 
under non-pathological conditions (Mitaka 1998; Gupta 2000).  
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Most functions within the liver are executed by hepatocytes characterized by high 
metabolic capacity. Therefore, hepatocytes are typically polyploid and polynuclear 
cells. Up to 40-50% hepatocytes contain two or more nuclei. Multinucleated 
hepatocytes develop mainly through endomitosis, in which mitosis is aborted prior to 
cytokinesis. Polyploidy in hepatocytes can further be induced by endoreplication – a 
process involving replication of DNA without nuclear division and subsequent mitosis. 
In addition, several studies demonstrated that polyploid hepatocytes can also be 
generated through fusion of a bone marrow-derived cell and a host hepatocyte in vivo 
(Wang et al. 2003; Willenbring et al. 2004; Duncan et al. 2010). Recently, it was also 
shown that cell fusion between hepatocytes is a physiological process in the murine 
liver (Faggioli et al. 2008; Faggioli et al. 2011).  
 
1.1.3 Liver regeneration and two-thirds partial hepatectomy 
 
In the healthy liver, mature hepatocytes are long lived quiescent cells with little 
turnover. However, in response to injury the liver displays remarkable regenerative 
capabilities for recovery of mass and functions. This fascinating process is best 
illustrated by liver growth after surgical resection of two-thirds of its mass, the 
standard partial hepatectomy (PH) procedure pioneered by Higgins and Anderson in 
1931 and now commonly used to study liver regeneration (Higgins and Anderson 
1931; Michalopoulos 2010). In this model, three liver lobes (left lateral, left middle and 
right middle lobe) constituting approximately 70% of liver mass are surgically removed. 
As a consequence, the remaining liver enlarges until the original liver mass is restored. 
This process is based on a compensatory hypertrophy and hyperplasia of the 
remaining tissue rather than on a true regenerative process, where the excised 
structure can reconstitute such as the regeneration of limbs in amphibian models. In a 
mouse model of 2/3 PH, original liver mass can be restored approximately within 7-10 
days following surgery with a peak of DNA synthesis after approximately 42 h with 
some variation depending on the genetic mouse background (Fausto and Riehle 
2005).  
Liver regeneration following PH proceeds in a highly ordered fashion (Figure 1.1). 
The several steps of liver regeneration are regulated by integrated multiple pathways 
involving cytokines, growth factors and metabolic networks (Fausto et al. 2006). As a 
simplified model, liver regeneration can be divided into three distinctive phases: the 
initiation or priming phase, where quiescent hepatocytes are rendered in a state of 
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replicative competence; the proliferation phase, where up to 95% of previously 
quiescent hepatocytes re-enter cell cycle; and the termination phase, where cell 
proliferation in liver is suppressed in order to terminate regeneration at a defined time 
point (Zimmermann 2004; Fausto and Riehle 2005).  
 
Figure 1.1: Multistep model of liver regeneration after PH (modified from Fausto et al. 2006). 
Liver regeneration can be divided into three phases: the priming phase, the proliferation phase 
and the termination phase. Cytokines and growth factors play a crucial role for regulating this 
process.  
 
Cytokine pathways are largely responsible for the priming phase. The well-known 
key-players in the cytokine network are the pro-inflammatory molecules Tumor 
Necrosis Factor (TNF) and Interleukin-6 (IL-6), which are mainly produced by Kupffer 
cells, the resident macrophages of the liver. Expression of TNF and IL-6 is induced 
very rapidly after PH and primes hepatocytes to enter the cell cycle and to respond to 
the mitogenic effect of growth factors. Subsequent to priming, so called “immediate 
early genes” are induced within 2 hours after PH. These genes are predominantly 
transcription factors (e.g. c-fos, c-jun and c-myc), which activate the gene expression 
of downstream mediators involved in liver regeneration. Studies using microarray 
analysis revealed that approximately 185 genes are regulated during the priming 
phase of liver regeneration (Su et al. 2002). 
In the proliferation phase at least three growth factors are of major importance: 
Hepatocyte Growth Factor (HGF), Transforming Growth Factor-alpha (TGFα) and 
Heparin-binding epidermal Growth Factor-like growth factor (HB-EGF). HGF is 
produced by non-parenchymal cells in the liver and also in other tissues and therefore 
stimulates hepatocytes in a paracrine or endocrine manner (Pediaditakis et al. 2001). 
G0 G1
S
M
G2
Priming
Cytokines
(TNF, IL-6)
Termination
(TGFß, activin)
Growth factors
(HGF, TGFα, HB-EGF)
Proliferation
Cell cycle
Proliferation
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Both TGFα and HB-EGF are members of the Epidermal Growth Factor (EGF) family. 
TGFα is synthesized by hepatocytes and acts in an autocrine manner. HB-EGF is 
strongly induced after PH and further precedes expression of HGF and TGFα. There 
is evidence that HB-EGF links the priming and proliferation phase of liver regeneration 
(Mitchell et al. 2005). Following mitogenic stimulation by cytokines and growth factors, 
hepatocytes seem to autonomously undergo proliferation without extracellular stimuli. 
Details about the subsequent cell cycle progression will be described in chapter 1.2. 
Once the restoration of liver functions and liver mass is completed, the induced 
regenerative response must finally be terminated. Major factors involved in the 
termination phase comprise TGFβ and activins, which can inhibit DNA synthesis in 
hepatocytes. However, the precise molecular mechanisms responsible for the 
termination of liver regeneration are still poorly understood (Michalopoulos 2007; 
Böhm et al. 2010).  
 
1.2 Cell cycle regulation in vertebrates 
 
The cell cycle in eukaryotic cells consists of four distinct phases: G1 
(Gap1)-phase, S-phase (DNA-synthesis), G2 (Gap2)-phase and M-phase (mitosis), 
respectively. The first three phases are collectively known as interphase. In addition, 
quiescent cells such as mature hepatocytes reside in a reversible non-replicative 
phase termed G0-phase.  
From yeast to humans, the cell cycle is driven by a group of heterodimeric 
serine/threonine kinases known as cyclin-dependent kinases (Cdks). In yeast, a 
single Cdk (Cdc28 in Saccharomyces cerevisiae and Cdc2 in Schizosaccharomyces 
pombe) drives all phases of cell cycle, while in mammalian cells the sequential 
activation of at least four different Cdks (Cdk1, equivalent to Cdc2, Cdk2, Cdk4 and 
Cdk6) is responsible for the whole process. Accordingly, four cyclin families 
specifically activate corresponding Cdks via complex formation in different phases of 
cell cycle: CcnD 1 (CcnD1, CcnD2 and CcnD3) activate Cdk4 and Cdk6; CcnE 
(CcnE1 and CcnE2) activate Cdk2; CcnA (CcnA1 and CcnA2) activate Cdk2 and 
Cdk1; CcnB (B1, B2 and B3) activate Cdk1 (Satyanarayana and Kaldis 2009).  
1 Nomenclature for cyclin: Ccn stands for cyclin. CcnD is referred for all there D-type cyclins, it is valid as 
same as for CcnE, CcnA and CcnB. Single cyclin is referred as e.g. CcnD1 or CcnE1.   
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Figure 1.2: Cell cycle machinery and Rb-E2F pathway (modified from Giacinti and Giordano 
2006). Specific Cdk/cyclin complexes regulate cell cycle progression. In G0 and early G1 
phase, unphosphorylated Rb physically associates with the E2F transcription factors. In late 
G1 phase, p-Rb phosphorylated by Cdk4/6-CcnD and Cdk2/CcnE releases E2F, allowing the 
expression of cell cycle genes necessary for S-phase progression.  
 
Extracellular stimuli such as cytokines and growth factors drive quiescent cells 
(G0-phase) into G1-phase as described previously. Subsequent progression of the 
cell cycle through each phase is precisely regulated by fluctuating activation of 
Cdk/cyclin complexes (Figure 1.2). The composition and regulation of Cdk/cyclin 
complexes vary depending on cell type and environment. Briefly, under normal 
conditions the mammalian cell cycle starts with expression of D-type cyclins, which 
are induced by extracellular mitogens. The key event in G1 phase is phosphorylation 
and thus inactivation of the retinoblastoma protein Rb and its homologues p107 and 
p130. Cdk4/CcnD and Cdk6/CcnD complexes phosphorylate specific residues of Rb, 
which leads to release of E2F and induction of early E2F responsive genes such as 
CcnE. CcnE activates Cdk2 in the later G1 phase resulting in completion of Rb 
phosphorylation and further induction of E2F responsive genes. Cells are then 
prepared to passage through the restriction point at boundary of G1/S phase. Until 
cells have reached the restriction point, the process of cell cycle initiation is fully 
revertible by depleting growth factors (Morgan 1997). 
S-phase of the cell cycle is defined as the time interval necessary for 
DNA-synthesis. In S-phase, CcnA2 together with Cdk2 and Cdk1 orchestrates the 
process of DNA-replication. Once DNA replication is finished, cells enter G2 phase, 
where Cdk1/CcnA2 kinase complexes prepare the cells for mitosis. For progression 
through mitosis the association of Cdk1 with B-type cyclins is essential. Along with the 
cell cycle, diverse checkpoints (G1/S, intra S-phase, G2/M and intra mitosis) 
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determine further progression or arrest. For this control, Cdk inhibitors (CKIs) 
involving Ink4 family (p15Ink4b, p16Ink4a, p18Ink4c and p19Ink4d) and Cip/Kip (p21Cip1, 
p27Kip1 and p57Kip2) family play crucial roles by preferentially inhibiting Cdk4/6 and 
Cdk2 complexes, respectively (Sherr and Roberts 1999). 
 
1.2.1 Origin licensing and G1/S-transition 
 
In S-phase, the chromosomal DNA has to be precisely replicated without errors 
exactly once per cell cycle. To accomplish this challenging task for the cell, a tightly 
coordinated process for initiation of replication involving more than 20 proteins has 
been evolved in eukaryotic cells (Bell and Dutta 2002). The mechanism of initiation 
comprises origin recognition, assembly of pre-replication complexes (pre-RC), 
helicase activation and replisome loading. 
 
Figure 1.3: Assembly of the pre-RC (adapted from Takeda and Dutta 2005). Origin licensing 
begins with the loading of ORC onto replication origins. ORC recruits Cdc6 and Cdt1, which 
are essential for the subsequent loading of multiple Mcm2-7 complexes at each origin.  
 
This process already starts normally during early G1 phase with recruitment of a 
group of six related proteins collectively referred to as the origin recognition complex 
(ORC) to replication origins prior to S phase (Figure 1.3). The proteins constituting the 
ORC complex are conserved from yeast to humans, whereas the recruitment 
mechanisms vary largely between simple and higher eukaryotes. However, the 
subsequent steps are highly conserved among all eukaryotes. ORC recruits the 
initiation factors Cdc6 and Cdt1 to origins, which promotes the loading of the 
heterohexameric MCM2-7 complex. It has been shown that the MCM2-7 complex 
serves as the replicative helicase during DNA-synthesis and is required for unwinding 
the origin (Walter and Newport 2000; Labib and Diffley 2001; Labib et al. 2001; 
Forsburg 2004). A recent study using CcnE knockout mice showed that E-type cyclins 
facilitate the loading of MCM2-7 complexes on chromatin through physical interaction 
with Cdt1 (Geng et al. 2007). Once MCM2-7 complexes are loaded onto chromatin, 
the assembly of pre-RC is completed. From then on, the other components of the 
pre-RC are dispensable for replication initiation.  
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The loading of the MCM complex represents the license for replication. The 
precise regulation of pre-RC formation is of high relevance to ensure that DNA 
replication occurs only once per cell cycle. In this scenario, Cdk/cyclin complexes 
belong to the primary regulators besides their well-established role in driving cell cycle 
progression. For pre-RC formation in G1-phase, overall low Cdk activity is required. In 
contrast, high Cdk activity is responsible for both removing the licence and preventing 
relicensing in S-phase. High Cdk activity persists until the next round of cell cycle to 
avoid re-replication (Coverley et al. 2002).  
 
1.2.2 Functional redundancy of interphase Cdks and associated cyclins 
 
The presence of phase-specific activation of Cdks by multiple cyclins in higher 
eukaryotic cells led to the prediction that each Cdk/cyclin complex carries unique 
phase-related functions. Experiments blocking kinase activity of different Cdks in vitro 
nicely demonstrated the correlation between cell cycle arrest in one specific phase 
and inhibition of the responsible kinase (Th'ng et al. 1990; Yasuda et al. 1991; van 
den Heuvel and Harlow 1993).  
Intriguingly, in vivo studies using gene targeting in mice revealed widespread 
redundancy among mammalian Cdks and also of cyclins in most cell types. The first 
evidence came from studies using knockout mice with depletion of individual D-type 
cyclins, which displayed overall normal development besides some abnormalities in 
individual cell types (Fantl et al. 1995; Sicinski et al. 1995; Sicinski et al. 1996; Huard 
et al. 1999; Lam et al. 2000; Sicinska et al. 2003). It appears that deletion of a single 
D-type cyclin can be substituted by its siblings in the majority of cell types. In line with 
this idea, expression of the CcnD2 gene knocked into the original CcnD1 locus 
rescued the phenotype of CcnD1-/- mice (Carthon et al. 2005). However, each D-type 
cyclin also performs essential functions in specific cell types, e.g. CcnD1 in retina, 
mammary glands and neurons, CcnD2 in B lymphocytes and pancreatic ß-cells, and 
CcnD3 in T lymphocytes (Huard et al. 1999; Solvason et al. 2000; Kowalczyk et al. 
2004). Further investigation in cells and mice with combined depletions of two or all 
three D-type cyclins revealed that loss of D-type cyclins may also be compensated by 
E- or A-type cyclins (Ciemerych et al. 2002; Kozar et al. 2004; Pagano and Jackson 
2004). For instance, murine embryonic fibroblasts (MEFs) lacking all D-type cyclins 
can still go through cell cycle and divide suggesting that E- or A-type cyclins can take 
over functions of D-type cyclins at least in some cell types (Kozar et al. 2004). In line 
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with this hypothesis, expression of human CcnE1 knocked into the original CcnD1 
locus also rescued the phenotype of CcnD1-/- mice (Geng et al. 1999). 
The catalytic partners of the D-type cyclins, Cdk4 and Cdk6, share 71% structure 
identity and can both interact with all three D-type cyclins to phosphorylate Rb. Mice 
lacking either Cdk4 or Cdk6 are viable and display similar abnormalities as observed 
in mice lacking D-type cyclins (Rane et al. 1999; Tsutsui et al. 1999; Malumbres et al. 
2004). It appears that Cdk4 and Cdk6 can compensate for each other in most cells. 
However, specific roles of Cdk4 or Cdk6 were also observed in several cell types, 
which might be attributed to distinct substrate specificity and subcellular localization 
(Rane et al. 1999; Franklin et al. 2000; Martin et al. 2003; Malumbres et al. 2004). In 
the case of combined deletion of both Cdk4 and Cdk6, Cdk2 can probably take over 
their functions via complex formation with D-type cyclins (Malumbres et al. 2004).  
Similar to the case of CcnD associated complexes, none of the components of 
the Cdk2/CcnE (i.e. CcnE1 or CcnE2) complexes are absolutely required for mouse 
development and cell cycle progression, which is surprising as the Cdk2/CcnE 
complexes were once believed to be essential for G1/S transition in all mammalian 
cells (Berthet et al. 2003; Geng et al. 2003; Ortega et al. 2003). However, combined 
deletion of both CcnE1 and CcnE2 results in embryonic lethality although this is rather 
due to placental defects involving impaired endoreplication of trophoblast giant cells. 
Surprisingly, CcnE-deficient MEFs proliferate actively under conditions of continuous 
cell cycling but are unable to re-enter the cell cycle from the quiescent G0 state (Geng 
et al. 2003). 
Further investigations uncovered a novel function of CcnE in assembly of the 
pre-replication complex (pre-RC) during initiation of DNA-synthesis, which is essential 
for endoreplication of trophoblast giant cells and megakaryocytes as well as for 
re-entering the cell cycle from quiescence (Geng et al. 2007). The deletion of Cdk2, 
which presents the canonical binding partner of E-type cyclins, does not reproduce 
any of the phenotypes observed in CcnE1-/-CcnE2-/- double knockout mice indicating 
that at least some of the functions of E-type cyclins are Cdk2-independent (Berthet et 
al. 2003; Ortega et al. 2003; Geng et al. 2007). Several studies suggest that Cdk4 and 
Cdk1 might contribute to the compensatory mechanism in the absence of Cdk2 
(Aleem et al. 2005; Jablonska et al. 2007; Santamaria et al. 2007; Satyanarayana et 
al. 2008b). In this line of evidence, Cdk2-/-Cdk4-/- double knockout mice die during 
embryonic development due to heart defects indicating overlapping function between 
Cdk2 and Cdk4 at least in cardiomyocytes (Berthet et al. 2006). Another study 
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showed that Cdk4 compensates for loss of Cdk2 in neural progenitor cells of the 
subventricular zone (Jablonska et al. 2007).  
In addition, it was demonstrated that Cdk1 can take over the function of Cdk2 
under several conditions (Aleem et al. 2005; Santamaria et al. 2007). Most strikingly, 
mouse embryos lacking Cdk2, Cdk4 and Cdk6 develop normally until mid-gestation. 
Except for some cell types such as hematopoietic cells and cardiomyocytes, other 
cells do not display obvious cell cycle defects in absence of all interphase Cdks. It 
seems that Cdk1 alone is sufficient to drive the cell cycle in the majority of mammalian 
cell types, which mimics the situation in yeast (Santamaria et al. 2007).  
Owing to the essential role of Cdk1 for mitosis, deletion of Cdk1 leads to early 
embryonic lethality (Diril et al. 2012). No evidence so far indicated that other Cdks can 
compensate for the loss of Cdk1. Even when Cdk2 is directly expressed from the 
Cdk1 locus, it still leads to early embryonic lethality (Satyanarayana et al. 2008a). 
Cdk1 can interact with either A-type cyclins (CcnA1 and CcnA2) or B-type cyclins 
(CcnB1, CcnB2 and CcnB3). Expression of CcnA1 is restricted to testes and CcnA1-/- 
mice are viable and develop normally (Liu et al. 1998). In contrast, CcnA2 is 
expressed ubiquitously and genetic ablation of CcnA2 leads to early embryonic 
lethality indicating an essential role for early embryogenesis (Murphy et al. 1997). A 
recent study reported that acute ablation of CcnA alone in MEFs led to prolonged 
expression of CcnE without affecting cell proliferation, while CcnA seems to be 
indispensable for cell proliferation of hematopoietic and embryonic stem cells. 
Concomitant deletion of both E- and A-type cyclins completely extinguished cell 
division (Kalaszczynska et al. 2009). 
Similar to CcnA1, expression of CcnB3 is also restricted to testes and fetal 
ovaries (Nguyen et al. 2002). The precise functions of CcnB3 in mouse 
embryogenesis and development are still unknown since CcnB3-/- mice have not been 
described so far. However, CcnB1-/- and CcnB2-/- mice have been generated. CcnB1-/- 
mice died before day 10.5 p.c., while CcnB2-/- mice are viable suggesting that CcnB1 
can fully compensate the loss of CcnB2 (Brandeis et al. 1998). 
Taken together, among the Cdk/cyclin network in mammals Cdk1 is the only 
cyclin-dependent kinase that cannot be replaced by other interphase Cdks and its 
binding partners (CcnA2 and CcnB1) appear to be the most non-redundant cyclins. 
Functional redundancy of other interphase Cdks and cyclins complicates the analysis 
of cell cycle mechanisms in vivo and requires their conditional inactivation in mice to 
study their role during embryogenesis and in adult organs.  
9 
 
 Introduction 
1.3 Cell cycle inhibition by the kinase inhibitor Roscovitine as a 
potential anti-cancer therapy 
 
Cdk activity is often increased in proliferative diseases such as cancer, owing to 
deregulation of cell cycle pathways frequently leading to overexpression of Cdk 
activators (cyclins) and/or inactivation of Cdk inhibitors. Thus, the development of 
small-molecule Cdk inhibitors for cancer therapy has been an intense area of 
research in the last decades (Malumbres et al. 2008).  
(R)-Roscovitine (also referred to as Seliciclib or CYC202) is a second-generation 
Cdk kinase inhibitor. It belongs to a group of substituted purines with a basic ring 
structure, which can mimic the ATP molecule therefore act by directly competing with 
ATP for binding to the catalytic site of the kinase (Meijer and Raymond 2003). 
Compared to other broad-range kinase inhibitors such as Flavopiridol and 
Olomoucine, Roscovitine displays a high specificity towards Cdk2, Cdk1, Cdk7 and 
Cdk5 (Meijer et al. 1997).  
An abundance of biochemical studies on a wide variety of cultured cells 
demonstrated that Roscovitine basically mediates two major effects: cell cycle arrest 
and cell death. Roscovitine inhibits cell cycle progression in different cell cycle phases 
depending on the cell line, the dose and the duration of treatment (Wesierska-Gadek 
et al. 2009b). This effect is mainly attributed to the direct inhibition of Cdks (Alessi et al. 
1998; Lacrima et al. 2005; Payton et al. 2006). However, indirect effects of 
Roscovitine cannot be excluded. For instance, Roscovitine inhibits the Cdk-activating 
kinase (CAK), Cdk7, which in turn impedes other Cdk activities (Wesierska-Gadek et 
al. 2009a). As a consequence, direct and indirect inhibition of Cdks by Roscovitine 
results in impairment of many essential events for cell cycle progression such as DNA 
replication initiation, centrosome duplication and nuclear envelope breakdown 
(Matsumoto et al. 1999; Sirri et al. 2002).   
The cell death-inducing effect of Roscovitine was initially thought to result from 
cell cycle arrest. However, increasing evidence indicates that rather inhibition of 
Cdk7/9-dependent transcription by Roscovitine triggers cell death mechanisms. Both 
Cdk7 and Cdk9 contribute to activation of RNA-polymerase II via phosphorylation of 
its C-terminal domain. The lack of phosphorylation reduces mRNA synthesis, which 
eventually leads to cell death in several investigated cell lines (Ljungman and Paulsen 
2001; MacCallum et al. 2005). Subsequent studies demonstrated that Roscovitine 
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inhibits transcription of essential cell survival factors such as Mcl-1, XIAP and Survivin 
(Kim et al. 2004; Alvi et al. 2005; Lacrima et al. 2005; Mohapatra et al. 2005).  
For its ability to inhibit cell cycle progression and induce cell death, Roscovitine 
treatment becomes an ideal candidate for anti-tumor therapy. Moreover, the short 
half-life of Roscovitine and the lack of activity of its metabolites might sensitize tumor 
cells to cell death but prevent normal cells from an irreversible inhibition. Due to its 
anti-tumor effect, Roscovitine has reached phase 2 clinical trials for B-cell 
malignancies, lung and breast cancer (Aldoss et al. 2009).  
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1.4 Aim of this study 
 
Previous studies using gene-targeting techniques demonstrated that mice 
lacking Cdk2 develop normally besides meiotic failure. Cdk2 appears dispensable for 
cell proliferation of most cell types. However, cell type specific functions of Cdk2 are 
not well characterized. Previous studies revealed conflicting results about the role of 
Cdk2 for liver regeneration. Therefore, the first aim of the current study was to 
examine the role of Cdk2 for hepatocyte proliferation and liver regeneration in the 
well-established model of partial hepatectomy (PH) in mice. For this purpose, 
conditional, hepatocyte-specific Cdk2 knockout mice should be generated for the first 
time as part of this study and subjected to PH.  
Based on the initial result that loss of Cdk2 in hepatocytes does not significantly 
impair liver regeneration, the second aim of this study was to identify molecules and 
mechanisms that compensate the loss of Cdk2 in the murine liver. This work package 
was based on the hypothesis that CcnE1 mediates important, Cdk2-independent 
functions in the regenerating liver and should analyze the expression, localization and 
function of CcnE1 in the Cdk2-deficient liver. 
The last aim was to precisely dissect the contributions of all components of the 
Cdk2/CcnE complexes (Cdk2, CcnE1 and CcnE2) for cell cycle progression of 
hepatocytes in vitro and in vivo. For this purpose, mouse mutants harbouring all 
possible combinations of Cdk2 and CcnE1/CcnE2 knockout alleles should be 
generated with the ultimate aim to substantially block hepatocyte proliferation in vitro 
(in ex vivo isolated primary hepatocytes) or in vivo (after PH). This knowledge gained 
from the liver regeneration model will also be of clinical relevance as it could help to 
block aberrant proliferation of hepatocytes in hepatocellular carcinomas or in other 
liver diseases with extensive cell proliferation such as chronic hepatitis or liver 
fibrosis. 
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2. Material and Methods  
2.1 Material 
2.1.1 Chemicals 
 
Name of the product   Company 
Ammoniumpersulfate (APS)  AppliChem 
Acetone  J.T.Baker 
Agarose  Invitrogen 
Acetic acid (glacial) 100%  AppliChem 
Ammoniumacetate  AppliChem 
Adenosin-5’-triphosphate (ATP)  Sigma-Aldrich 
[32P]-γ-ATP (10mCi/ml)  Hartmann Analytic 
Bromophenol Blue  Serva 
Bovine Serum Albumin(BSA)  Sigma-Aldrich 
Calciumchloride (CaCl2)  Sigma-Aldrich 
Chloroform  Merck 
Dithiotreitol (DTT)  Sigma-Aldrich 
Dodecylsulfate (SDS)  Roth 
Ethylene-diamine-tetraacetatic acid (EDTA) Calbiochem 
Ethylene-glycol-tetraacetic acid (EGTA) Fluka 
Eosine  Sigma-Aldrich 
Ethanol 100%  AppliChem 
Ethidiumbromide (EtBr)  Sigma-Aldrich 
Formaldehyde 37%  Roth 
Glucose  Merck 
Glutaraldehyde  AppliChem 
Glycerol   Sigma-Aldrich 
Glycine  AppliChem 
Haematoxyline / Eosin (HE)  Merck 
Hydrochloric acid (HCl)  AppliChem 
4-(2-hydroxyethyl)-1-piperazine-ethane-sulfonic acid (HEPES) Merck 
Magnesiumchloride (MgCl2)  Sigma-Aldrich 
100% Methanol  VWR 
Nonidet P-40  Sigma-Aldrich 
Paraformaldehyde  Merck 
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Ponceau Red  Sigma-Aldrich 
Potassiumchloride (KCl)  Merck 
2-Propanol  Merck 
Sodiumfluoride (NaF)  Roth 
Sodiumvanadate (Na3VO4)  Sigma-Aldrich 
Tetramethyl-ethylene-diamine  TEMED 
Tris Buffer grade  AppliChem 
Triton X-100  Sigma-Aldrich 
TWEEN-20  Serva 
 
2.1.2 Enzymes, reagents and kits 
 
Name of the product   Company 
Acrylamide Solution 30%  Biorad 
Accutase   eBioscience 
Bacteriophage T4 polynucleotide kinase  NEB 
BioRad Protein Assay  Biorad 
Collagen Type I from rat tail  Sigma-Aldrich 
Collagenase Type II  Worthington 
cOmplete Mini, Protease Inhibitor Cocktail Tablets  Roche 
Covering solution for cryo sections (Tissue-Tek®) Sakura 
Diaminobenzidine (DAB)  Sigma-Aldrich 
DNA marker 1kb plus Ladder®  Invitrogen 
ECLTM Prime Western Blotting Detection Reagent GE Healthcare 
EGF Sigma-Aldrich 
Hot Star Taq Master Mix Kit  Qiagen 
Insulin  Novo Nordisk 
Omniscript RT PCR Kit  Qiagen 
Proteinase K  AppliChem 
QIAzol® lysis reagent  Qiagen 
Red Taq  Sigma-Aldrich 
RNeasy Lipid Tissue Mini Kit  Qiagen 
SuperSignal® West Pico Chemiluminescent Substrate Pierce 
SYBR® GreenER qPCR SuperMix  Invitrogen 
Vectashield Mounting Medium with DAPI Vector 
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2.1.3 Antibodies 
2.1.3.1 Primary antibodies 
 
Antibody   Company 
Anti-BrdU  GE Healthcare 
Anti-Cdc2 (p34, H-297; sc-747)  Santa Cruz Biotechnology 
Anti-Cdk2 (M2; sc-163)  Santa Cruz Biotechnology 
Anti-Cdk4 (C-22; sc-260)  Santa Cruz Biotechnology 
Anti-Cdk6 (C-21; sc-177)  Santa Cruz Biotechnology 
Anti-Cdt1 (H-300; sc-28262)  Santa Cruz Biotechnology 
Anti-HNF4α (C-19; sc-6556)  Santa Cruz Biotechnology 
Anti-Cyclin A (C-19; sc-596)  Santa Cruz Biotechnology 
Anti-Cyclin D1 (72-13G; sc-450)  Santa Cruz Biotechnology 
Anti-Cyclin E (M20; sc 481) Santa Cruz Biotechnology 
Anti-Cyclin E1 MILLIPORE 
Anti-GAPDH AbD SeroTec 
Anti-Histone H3 Cell signaling Technology 
Anti-Ki-67 (NCL-Ki67p) Leica 
Anti-MCM2 (N-19; sc-9839) Santa Cruz Biotechnology 
Anti-p16 (M-156; sc-6397)  Santa Cruz Biotechnology 
Anti-p21Kip1 (C-19; sc-6397) Santa Cruz Biotechnology 
Anti-p27Kip1  BD Pharmingen 
Anti-PCNA Invitrogen 
Anti-pRb (Ser807/811) Cell signaling 
Anti-Rb (M-153, sc-7905) Santa Cruz Biotechnology 
 
2.1.3.2 Secondary antibodies 
 
Antibody   Company 
chicken anti-mouse IgG-HRP  Santa Cruz Biotechnology 
chicken anti-rat IgG-HRP Santa Cruz Biotechnology 
rabbit anti-goat IgG-HRP Santa Cruz Biotechnology 
goat anti-rabbit IgG-HRP Cell Signaling Technology 
Alexa 488 donkey anti-mouse Invitrogen 
Alexa 488 rabbit anti-rat Invitrogen 
Alexa 546 goat anti-rabbit Invitrogen 
Alexa 546 rabbit anti-goat Invitrogen 
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2.1.4 Solutions, buffers and media 
 
Name of product   Company 
DMEM Invitrogen 
EBSS negative Gibco 
EBSS positive Gibco 
Fetal Calf Serum (FCS) PAA 
PBS pH 7,4, 1x and 10x Gibco 
Penicillin/Streptomycin (P/S) Gibco 
 
2.1.5 Instruments and equipments 
 
Name of product   Company 
7300 Real Time PCR System with 
Sequence Detection Software Version 1.3.1. Applied Biosystems 
Blotting Trans-BlotTM Cell BioRad 
Cell culture incubator Heraeus 
Centrifuge 5415D Eppendorf 
Cooling centrifuge 5417R Eppendorf 
Cryostat HM 550 Microm 
ELISA Reader μQuant +KC4 Software BIO-TEK 
LAS mini 4000 Fuji 
Overhead shaker REAX 2 Heidolph 
Perfusion pump Ismatec 
pH Meter PB-11 Sartorius 
Power supply PowerPacTM HC BioRad 
Roller Mixer SRT 9 Stuart 
Rotating incubator Bachofer 
SDS PAGE electrophoresis system  PeQLab 
Shaking incubator Unimax 1010 Heidolph 
Thermocycler T3000 and Tpersonal Biometra 
Thermomixer 5436 Eppendorf 
Water bath Haake W13 Fisons 
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2.1.6 Consumables 
 
Name of product   Company 
96 well Microplates for RT-PCR Star LAB 
96 wells Microplates for protein measurements Greiner 
96 wells Microplates for RNA measurements (UV-STAR) Greiner 
Catheter with injection port (Biovalve® 20G; 1,0x32mm) Vygon 
Disposable scalpels sterile No. 11 Feather 
Eppendorf tubes 1ml, 1,5 and 2,0ml Eppendorf 
ETHIBOND* EXCEL 2-0 P6937H, non-absorbable suture ETHICON 
Hematocrit capillary Brand 
Heparine (Liquemin®) Roche 
Injection needles (Sterican®; Gr.17 24Gx25mm; 0,4x12mm) Braun 
Isoflurane (Forene®) Abbott 
Ketamine (Ketamin®) Albrecht 
Micro tube (1,1 ml Z-Gel) Sarstedt 
Multiply-PCR Strips Sarstedt 
Nitrocellulose membrane Protran® Whatman 
Super Frost slides Roth 
Surgical instruments Aesculap 
Syringe Omnican® Braun 
VICRYL* 4-0 V7980E, absorbable suture ETHICON 
X ray films Amersham 
Xylazin (Rompun®) Bayer 
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2.2 Methods 
2.2.1 Animal experiments   
2.2.1.1 Housing and breeding of mice 
 
Animals were housed under standardized conditions in the “Institut für 
Versuchstierkunde“ of the University Hospital of the RWTH Aachen. A 12-hours 
light/dark cycle, controlled temperature of 20 – 24°C and humidity of 50 – 60% were 
maintained. Mice were kept in macrolon cages with free access to food and water. All 
animal experiments were carried out according to the German legal requirements and 
animal protection law and approved by the government of the state North 
Rhine-Westphalia (LANUV, AZ 8.87-50.10.35.08.284).  
 
2.2.1.2 Knockout mouse strains 
 
Mice with a floxed allele of Cdk2 (Cdk2f/f) (Ortega et al. 2003) were obtained from 
M. Barbacid (CNIO, Madrid, Spain). The generation and characterization of Cyclin E1 
(CcnE1) knockout mice has been described in previous studies (Geng et al. 2003; 
Geng et al. 2007; Nevzorova et al. 2009). To generate hepatocyte-specific Cdk2 
knockout (Cdk2∆hepa) mice, Cdk2f/f animals were crossed with transgenic alfp-cre mice 
expressing cre-recombinase under control of albumin promoter – and α-fetoprotein 
enhancer elements in a C57BL/6 background (Kellendonk et al. 2000). 
These mice were further crossed with CcnE1-/- mice to obtain Cdk2∆hepaCcnE1-/- 
double knockout (DKO) mice. Cdk2f/f littermates were used as wildtype (WT) controls. 
 
2.2.1.3 Partial hepatectomy (PH)  
 
For liver regeneration studies 2/3 PH was performed as described earlier 
(Nevzorova et al. 2009). Briefly, male mice between 6-8 weeks of age were 
anesthetized by intraperitoneal (i.p.) injection of 0.3 ml Ketamin/Rompun anaesthetic 
per 20 g body weight. The abdominal cavity was opened with a midline laparotomy. 
The right lateral, the left lateral and left anterior liver lobes were removed. Afterwards 
peritoneum and dermis were closed separately. For Roscovitine treatment 50 mg/kg 
Roscovitine or vehicle (DMSO) were delivered by i.p. injections 28 hours (h) and 40 h 
after PH. To determine the S-phase progression 300 µl Bromodeoxyuridine (3 mg/ml) 
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was given by i.p. injection 2 h before sacrificing. For different indicated time points 
after PH, at least 5 mice per group were sacrificed by cervical dislocation.  
 
Anaesthetic 
Substance Volume 
Ketamine 450 µl  
Rompun 50 µl  
0.9% NaCl add 5 ml  
 
2.2.1.4 Isolation and cell culture of primary hepatocytes  
 
Primary mouse hepatocytes were isolated from 6-8 week old mice by 
collagenase perfusion. Mice were anesthetized by i.p. injection of 0.3 ml 
Ketamin/Rompun anaesthetic per 20 g body weight and followed by anti-coagulation 
treatment with 300 µl (50 I.E.) heparin solution. After opening the abdominal cavity 
with a caudocranial cut in the linea alba, the vena portae was cannulated with an 
intravenous catheter (Biovalve 20G). Immediately after cutting the vena cava caudalis 
the liver was rinsed with EBSS negative buffer including 250 µl EGTA solution (100 
mM, pH 8.3) in a flow rate of 6 ml/min until the hepatic vascular system was clarified 
from blood. The perfusion was continued with 30 ml EBSS positive buffer. Ultimately, 
the liver was perfused with 50 ml EBSS positive buffer containing 30 mg collagenase 
type II and 2 mg trypsin inhibitor. Afterwards the abrogated liver was withdrawn and 
hepatocytes were released in ice cold DMEM medium. After filtering through sterile 
gossamer, cell suspension was centrifuged at 50 g at 4°C for 3 minutes to sediment 
hepatocytes from other cell populations and cell residues. The suspension was 
discarded and the pellet was washed again with DMEM medium. Finally the washed 
pellet was resuspended in DMEM medium containing 10% fetal calf serum (FCS) and 
penicillin/streptomycin (100 U/ml penicillin and 0.1 mg/ml streptomycin). Cell viability 
was determined microscopically by using trypan blue. Live cells were plated on 
collagen type I coated petri dishes at a density of 2X 105 /cm2. Cells were incubated at 
37°C with 5% CO2 supply. After 4 h incubation the culture medium was changed and 
non-adhered cells were washed away. Culture medium was changed every day. 
To stimulate cell proliferation, cells were given 10 ng/ml EGF and 2x10-2 IU/ml 
insulin every day. To inhibit cell proliferation, Roscovitine was used in cell culture at a 
concentration of 15 µg/ml. The use of the recombinant adenovirus over-expressing 
CcnE1 (adv-CcnE1) in liver and hepatocytes has been described previously 
(Nevzorova et al. 2009). 
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2.2.2 DNA and mRNA analysis 
2.2.2.1 Genotyping of genetically modified mice with PCR 
 
To determine the genotype of mice, DNA from tail biopsies was isolated and PCR 
was performed. For DNA isolation, tail biopsies from young mice were lysed in 200 µl 
NID lysis buffer and 1 µl Proteinase K at 56°C overnight on a thermo-mixer. 
Proteinase K was inactivated at 95°C for 10 minutes. After mixing vigorously the 
lysate was centrifuged for 10 minutes with maximum speed. For PCR 2 µl of the 
supernatant containing DNA was used as template.  
 
NID lysis buffer 
Substance Stock concentration Volume Final concentration 
Tris pH 8.3 1 M 10 ml 10 mM 
KCl 1 M 50 ml 50 mM 
MgCl2 1 M 2 ml 2 mM 
NP-40 - 4.5 0.45% 
Tween 20 - 4.5 0.45% 
Gelatine type III 10 mg/ml 10 ml 0.1 mg/l 
H2O  add 1l  
 
PCR  
Reagent Concentration Volume 
Taq master Mix1  2x  12.5 ml  
sense Primer  10 µM 1 µl  
antisense2 Primer 10 µM  1 µl  
DNA - 2 µl 
H2O - 7.5 µl 
1 Red Taq master mix for Cre, Cyclin E1, Cyclin E2; HotstarTaq master mix for Cdk2 
2 For detection of Cyclin E1 and E2 deletion in Cyclin E1 or E2 constitutive knock mice a third 
antisense primer was used. 
 
Target gene Sequence in 5’ – 3’ orientation 
Cre CCACGACCAAGTGACAGCAAT 
 TTCGGATCATCAGCTACACCA 
CcnE1 CGCCATGGTTATCCGGGAGATGG 
 CGCATACTGAGACACAGACT 
 GATCTCTCGTGGGATCATTG 
CcnE2 GGTTCTCCCATTTAGAGCACAG  
 GCTATAGCAGTTGTTTCTGTTTG 
 GATCTCTCGTGGGATCATTG 
Cdk2 CAAGTTGACGGGAGAAGTTGTG 
 GAAGACCCTCCAGGTGAATGAA 
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Cre PCR program 
Step Temperature Duration Cycle 
Initial Denaturation  95°C 5 min  1  
Denaturation  95°C 15 s   
Annealing 55°C 45 s  35 
Elongation 72°C 45 s  
Final Elongation 72°C 5 min 1 
Conservation 4°C ∞  
 
CcnE1 (for both constitutive and conditional mice) and CcnE2 PCR program 
Step Temperature Duration Cycle 
Initial Denaturation  94°C 3 min  1  
Denaturation  94°C 1 min   
Annealing 60°C 1 min  37 
Elongation 72°C 1 min  
Final Elongation 72°C 3 min 1 
Conservation 4°C ∞  
 
Cdk2 PCR program 
Step Temperature Duration Cycle 
Initial Denaturation  95°C 15 min  1  
Denaturation  94°C 15 s   
Annealing 53°C 30 s  32 
Elongation 72°C 30 s  
Final Elongation 72°C 2 min 1 
Conservation 4°C ∞  
 
PCR to determine deletion efficiency of Cdk2 gene 
Step Temperature Duration Cycle 
Initial Denaturation  95°C 5 min  1  
Denaturation  98°C 20 s   
Annealing 60°C 35 s  37 
Elongation 72°C 1 min  
Final Elongation 72°C 5 min 1 
Conservation 4°C ∞  
 
2.2.2.2 Isolation of mRNA from liver tissue 
 
From deep frozen liver tissue a small piece (about 50 mg) was transferred into 1 
ml peqGOLD-RNAPure®. After homogenization with an Ultra-Thurax® the lysate was 
incubated for 5 minutes at room temperature. Afterwards 200 µl (1/5 volume) 
chloroform was added and the mixture was agitated thoroughly for 15 seconds. After 
incubation for 10 minutes at room temperature the lysate was centrifuged at 12000x g 
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at 4°C. The upper phase containing mRNA (about 500 µl) was transferred carefully to 
a new tube and precipitated by adding 500 ml (1 volume) 2-propanol. After incubation 
for 10 minutes at room temperature mRNA was pelleted by centrifugation for 10 
minutes at 12000x g at 4°C. The supernatant was discarded and the pellet was 
washed twice with 1 ml 70% ethanol. The pellet was dried on ice and then dissolved in 
appropriate volume of RNAse-free water (about 50 µl). For long term storage mRNA 
was kept at -80°C. 
 
2.2.2.3 Isolation of mRNA from cell culture 
 
Cells (primary hepatocytes or Hepa1-6 hepatoma cells) were washed with cold 
PBS 3 times and collected to an eppendorf tube. After centrifugation at 1500x g and 
4°C supernatant was discarded and 500 µl QIAzol® lysis reagent were added. The 
tube containing the homogenate was incubated at room temperature for 5 minutes, 
and then 200 µl chloroform were added. After shaking vigorously for 15 seconds the 
tube was incubated again at room temperature for 3 minutes. Afterwards the tube was 
centrifuged at 12000x g for 15 minutes at 4°C. The upper aqueous phase was 
transferred to a new collection tube. One volume of 70% ethanol was added and 
thoroughly mixed by vortex. Without delay the mixture including any precipitate was 
pipetted into an RNeasy Mini Spin Column in a 2 ml collection tube. The tube with 
column inside was centrifuged at 12000 rpm for 30 seconds at room temperature. The 
flow-through was discarded. 350 µl Buffer RW1 were pipetted into the RNeasy mini 
column and centrifuged for 30 seconds at 12000 rpm. DNA was digested by 
incubating with Dnase I solution for 15 minutes at room temperature. Columns were 
washed once again with 350 µl buffer RWI and then 2 times with buffer RPE. To elute 
mRNA, 30-50 µl RNase-free water was added directly onto column membrane and 
centrifuged for 1 minute at 12000 rpm.  
 
2.2.2.4 Determination of nucleic acid concentration 
 
Isolated nucleic acid was diluted 1:50 in aqua bidest. (ddH2O) and its extinction 
was determined using ELISA Reader µQuant at 260 nm (E260). RNA concentration 
was calculated according to the formula (RNA concentration = 40 x E260 / 1000 [µg/µl]), 
while the calculation of DNA concentration was based on the formula (DNA 
concentration = 50 E260 / 1000 [µg/µl]). The purity of nucleic acid was determined with 
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an additional measurement of the optical density at 280 nm (E280); a ratio of E260 / E280 
between 1.8 and 2.1 reflects a suitable purity. 
 
2.2.2.5 Reverse Transcription (RT)-PCR 
 
To converse single-stranded mRNA into complementary DNA (cDNA) for further 
analysis of gene expression, reverse transcription was performed by using Omniscript 
RT Kit according to manufacturer’s recommendations.  
 
Component Volume / reaction 
10x Buffer RT 2 µl 
dNTP mix (5 mM each) 2 µl 
Oligo-dT primer 10 µM 2 µl 
Omniscript Reverse Transcriptase 1 µl 
Template RNA 2 µg 
ddH2O add 20 µl 
 
 
Temperature Time 
37°C 60 min 
95°C 5 min 
 
2.2.2.6 Quantitative real-time PCR 
 
To analyze the transcriptional expression level of cell cycle relevant genes, 
real-time PCR was performed by using a 7300 Real-Time PCR System with SDS 
software (version 1.3.1) and a SYBR Green PCR Kit (Invitrogen). The 2-∆∆Ct method 
was used to analyze the relative changes in gene expression from real-time 
quantitative PCR experiments (Livak and Schmittgen 2001). For this purpose the 
gene expression of GAPDH was used as internal control.  
 
Component Volume / reaction 
SYBR Green 12.5 µl 
Primer sense (10 nM) 1 µl 
Primer antisense (10 nM) 1 µl 
ddH2O 5.5 µl 
cDNA 5 µl 
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The following primers were used to detect transcriptional expression level of target 
genes as indicated. 
Gene Sense primer (5´ - 3´) Antisense primer (5´ - 3´) 
7SL GTGTCCGCACTAAGTTCGG TATTCACAGGCGCGATCC 
AFP CCCACTTCCAGCACTGCCTGCGG GGCTGCAGCAGCCTGAGAGTC 
Albumin  TGTCCCCAAAGAGTTTAAAGCTG  TCTTAATCTGCTTCTCCTTCTCTGG 
CcnD1  AAGCATGCACAGACCTTTGTGG  TTCAGGCCTTGCATCGCAGC 
CcnE1 TCCACGCATGCTGAATTATC TTGCAAGACCCAGATGAAGA 
CcnE2 AAAAAGTCTTGGGCAAGGTAAA GCATTCTGACCTGGAACCAC 
CcnA2 GTGGTGATTCAAAACTGCCA  AGAGTGTGAAGATGCCCTGG 
CD133 ACCTCACCATCCCGCATCT GAAAAGTTGCTCTGCGAACC 
Ck19 GGGGGTTCAGTACGCATTGG GAGGACGAGGTCACGAAGC 
E2F1 AGAGTGAGCAGCAGCTGGAT GGTCCTGGCAGGTCACATAG 
GAPDH TGTTGAAGTCACAGGAGACAACCT AACCTGCCAAGTATGATGACATCA 
Sox9 TGCCCATGCCCGTGCGCGTCAA CGCTCCGCCTCCTCCACGAAGGGTCT 
 
2.2.2.7 Analysis of DNA content by fluorescence activated cell sorting (FACS) 
 
Cultured hepatocytes were washed with cold PBS 3 times and then detached 
with Accutase. Cell suspension was centrifuged at 50 g for 5 minutes at 4°C. The 
pellet was washed again with cold PBS twice and then fixed with 4% PFA for 20 
minutes at room temperature. After washing twice with cold PBS cells were 
permeabilized in Nicoletti buffer for 15 minutes at room temperature. Cell suspension 
was centrifuged and washed with cold PBS. Permeabilized cells were incubated with 
PI/RNase solution for DNA staining. Samples were measured using a BD Canto flow 
cytometer. Data analysis was performed with FlowJo software version 7.6.  
 
2.2.2.8 Fluorescence in situ hybridization (FISH) 
 
Pre-hybridization and hybridization: Primary hepatocytes were cultured on cover 
slips (described in 2.2.1.4). Cover slips were washed with cold PBS 3 times and then 
fixed with 3:1 methanol:acetic acid for 5 minutes at room temperature and allowed to 
dry overnight. For aging, cover slips were baked for 5 minutes at 95°C and followed 
by incubation in 2xSSC for 30 minutes at 37°C. Cover slips were treated with 1% 
pepsin/0.01M HCl for 13 minutes at 37°C. After rinsing in 1xPBS for 5 minutes at room 
temperature, cover slips were fixed in 2.5% formaldehyde/0.45% MgCl2/PBS for 5 
minutes at room temperature. Cover slips were again rinsed in 1xPBS/2mM glycin 
(pH8.5) for 5 minutes at room temperature and then hydrated by 2 minutes washes in 
70%, 80%, 90% and 100% ethanol series. Once dried, 5 µl probes (Mouse & Rat 
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IDetectTM Chromosome Paint probe) were added to cover slips. Thereafter cover slips 
were sealed by rubber cement and incubated at 69°C for 2 minutes and at 37°C 
overnight. 
 
Post-hybridization: After incubation overnight cover slips were shortly put in 2x 
SSC/0.15% NP-40 and further washed in 0.4x SSC/0,3% NP-40 at 73°C for 2 minutes. 
Cover slips were washed again in 2x SSC/0.15% NP-40 for 1 minute at room 
temperature and mounted with DAPI mounting medium. Samples were analyzed 
using fluorescence microscopy. 
 
2.2.3 Protein analysis 
2.2.3.1 Protein isolation and quantification 
 
Total proteins from frozen liver tissues or cell pellets were extracted with ice cold 
NP40-Buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40 and 50 
mM NaF freshly supplemented with protease inhibitors (Complete Mini, Roche), 
phosphatase inhibitors (PhosSTOP, Roche) and 1 mM DTT.  
Nuclear proteins from frozen liver tissues were prepared by using 2 different lysis 
buffers Buffer A (10 mM HEPES pH 7.6, 10 mM KCl, 2 mM MgCl2 and 0.1 mM EDTA 
and Buffer C (50 mM HEPES pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA and 
10% Glycerol). Both buffers were freshly supplemented with Complete Mini, 
PhosSTOP and 1 mM DTT. Proteins from cytosol were extracted with Buffer A 
including 0.5% NP-40. After centrifugation the supernatants were used for cytosolic 
protein lysates. The pellet was extracted by Buffer C to get nuclear protein lysates.  
For isolation of chromatin fractions from primary hepatocytes, cells were 
incubated in ice cold CSK buffer (20 mM HEPES-KOH pH7.6, 40 mM potassium 
glutamate, 1 mM MgCl2, 1 mM EGTA and 300 mM sucrose freshly supplemented with 
Complete Mini, PhosSTOP and 1 mM DTT) with 0.1% Triton X-100 for 20 minutes. 
Extracts were centrifuged at 1500x g for 3 minutes and supernatants (soluble 
fractions) were collected. The pellets were extracted with CSK buffer without Triton 
X-100 and these insoluble fractions were used as chromatin fractions (modified from 
Geng 2003 and Okuno 2001). (Okuno et al. 2001) 
Protein concentrations were determined by BIO-RAD protein assay (BIO-RAD) 
according to manufacturer’s instruction. BSA solutions with different concentrations (1, 
2, 4, 6, 8 µg/µl) were used as protein standard. The absorbance of protein lysates and 
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protein standard was measured at 595 nm and protein concentration was calculated 
according to the BSA standard curve. Protein concentrations in insoluble chromatin 
fractions could not be measured reliably due to insoluble flocculent. Instead, in 
proportion to the protein concentration of soluble fractions the equalization was 
performed by adding CSK buffer.  
 
2.2.3.2 Western Blot 
 
Samples containing equal amount (50 µg) of protein were combined with 6x 
Laemmli sample buffer and boiled at 95°C for 5 minutes. Samples were separated by 
sodium dodecyl sulfate polyarylamide gel electrophoresis (SDS-PAGE). Separated 
proteins were transferred from gel to cellulose membrane (Whatman® Protran®) using 
a wet blotting system (BIORAD). Membranes were blocked for 1 h in blocking buffer 
(2.5% Dry-Milk in TBS-Tween) and then probed with appropriate antibodies in 
blocking buffer overnight at 4°C. After incubation membranes were washed with 
TBS-Tween 4 times for 5 minutes and then incubated with a HRP-linked secondary 
antibody for 1 hour in room temperature. Washing of membranes was performed 4 
times for 5 minutes in TBS-Tween and followed by incubating with ECL western 
blotting detection reagent. Proteins with ECL signals were detected by a digital 
detection system (FULJIFILM). GAPDH was used as loading control. TATA binding 
protein (TBP, abcam) was used as loading control for chromatin fractions and nuclear 
proteins. 
 
2.2.3.3 Immunoprecipitation and in vitro kinase assay 
 
Samples containing equal amount (500 µg) of protein were subjected to 
immunoprecipitation via incubating with 1 µg antibody at 4°C for 4 h and then 
conjugated to protein A/G PLUS agarose beads (Santa Cruz) for 2 h. The conjugated 
beads were collected by centrifugation at 2000 rpm and 4°C for 3 minutes and 
washed 3 times with NP-40 buffer and once with wash buffer. After washing beads 
were incubated with 30 µl kinase assay buffer containing substrate (Histone H1 or 
recombinant Rb), ATP and 32P-γATP at 30°C. Reaction was stopped by adding 6x 
SDS loading buffer and boiled at 95°C for 5 minutes. Samples were separated by 
SDS-PAGE using 10% Gel and analyzed by autoradiography. 
 
26 
 
 Material and Methods 
Buffer for Histone H1 kinase assay: 
 
Wash buffer (15 ml) 
Components Volume Final concentration 
0.5 M Tris-HCl (pH 7.4)   1.5 ml 50 mM 
1 M MgCl2 225 µl 15 mM 
1 M KCl 150 µl 10 mM 
0.1 M EGTA 150 µl 1 mM 
1 M DTT 15 µl 1 mM 
ddH2O add 15 ml  
 
Histone H1 kinase assay buffer (240µl) 
Components Volume Final concentration 
Wash buffer   227 µl  
10 mM ATP 1.2 µl 50 µM 
10 µCi/µl 32P-γATP 6 µl 0.25 µCi/µl 
20 µg/µl Histone H1 6 µl 0.5 µg/µl 
 
Buffer for Rb kinase assay: 
Wash buffer (15 ml) 
Components Volume Final concentration 
0.5 M HEPES ( pH 7.4)   1.5 ml 50 mM 
1 M MgCl2 225 µl 15 mM 
1 M KCl 150 µl 10 mM 
0.1 M EGTA 150 µl 1 mM 
PhosSTOP tablet 1 piece  
ddH2O add 15 ml  
 
Histone H1 kinase assay buffer (240µl) 
Components Volume Final concentration 
Wash buffer   223 µl  
10 mM ATP 1.2 µl 50 µM 
10 µCi/µl 32P-γATP 8 µl 10 µCi/30µl 
0.5 µg/µl Histone H1 8 µl 0.5 µg/30µl 
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2.2.4 Immunofluorescence 
2.2.4.1 Quantification of BrdU incorporation by immunofluorescence 
microscopy 
 
BrdU (5-bromo-2-deoxyuridine) incorporation and subsequent staining was used 
to quantify the number of cells in S-phase in vivo and in vitro. For in vivo labeling, 
BrdU was injected i.p. (30 µg / g body weight) 2 h before animals were sacrificed. 
Pieces of liver tissues were frozen in Tissue-Tek at -80°C. For staining, 5 µm 
cryosections on Superfrost slides were made and then air-dried at room temperature 
for 1.5-2 h and fixed with pre-chilled acetone at -20°C for 10 minutes. After 
rehydration in 1x PBS for 5 minutes, slides were treated with 2 M HCl for 30 minutes 
and then neutralized with 0.1 M sodium borate (pH 8.0) for 9 minutes. Slides were 
washed in tap water for 2 minutes 4 times and in PBS for 4 minutes 3 times. After 
washing, samples were incubated with anti-BrdU mouse monoclonal antibody (GE 
Healthcare, 1:4000 dilution) at 4°C overnight. On the second day, slides were washed 
in PBS for 4 minutes 3 times and then incubated with anti-mouse Alexa 488 antibody 
for 1 h at room temperature in the dark. Samples were then washed in PBS for 15 
minutes, mounted with DAPI containing mounting medium (Vector Laboratories) and 
covered with glass coverslips.  
For in vitro labeling primary hepatocytes, which were cultured on collagen-coated 
coverslips, were incubated with 20 µM BrdU for 2 h before fixation. Labeled cells were 
washed 3 times with cold PBS and fixed with pre-chilled acetone at -20°C for 10 
minutes. The subsequent steps were as described for the in vivo BrdU staining 
protocol. 
 
2.2.4.2 ß-catenin staining 
 
Cryosections of liver tissue were cut at 5 µm thickness and fixed in ice cold 
methanol for 20 min. After washing 3 times for 5 min in PBS, slides were first blocked 
with 5% goat serum in PBS (blocking buffer) and then incubated with a fluorescein 
conjugated anti-ß-catenin antibody (1:1000 dilution in blocking buffer) at 4°C 
overnight. On the following day, slides were washed in PBS for 5 min 3 times and then 
mounted with DAPI containing mounting medium and covered with glass coverslips 
for microscopical visualization.  
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2.2.4.3 Ki-67 and HNF4α co-staining 
 
Cryosections of liver tissue were cut at 5 µm thickness and fixed in 4% PFA for 15 
min at RT. After washing 3 times for 5 min in PBS, slides were first blocked in blocking 
buffer (5% donkey serum and 0.3% Triton X 100 in PBS) and then incubated with 
rat-anti-mouse Ki-67 antibody and goat-anti-mouse HNF4α antibody (both 1:500 
dilution in blocking buffer) at 4°C overnight. On the following day, slides were washed 
in PBS for 10 min 3 times and then incubated with Alexa 546 donkey anti-goat 
antibody and Alexa 488 donkey anti-rat antibody (both 1:200 dilution in blocking buffer) 
for 1 h at RT. Thereafter slides were washed for 10 min 3 times in PBS and then 
mounted with DAPI containing mounting medium and covered with glass coverslips 
for microscopical visualization.  
 
2.2.5 Electrophoretic mobility shift assay (EMSA) 
 
EMSA was performed to analyze the promoter regulation of the cyclin A2 gene. 
The method is based on the fact that labeled double-stranded oligonucleotides (probe) 
migrate faster through a non-denaturing polyacrylamide gel compared to specific 
protein-probe complexes indicating DNA-protein interactions.  
For the labeling of the probe, equal amounts of complementary single-stranded 
oligonucleotides (50 µg each) were added with 26 µl 10x annealing buffer (200 mM 
Tris-HCl, pH 7.6; 100 mM MgCl2; 500 mM NaCl) and H2O to a final volume of 260 µl. 
The mixture was incubated for 5 minutes at 95°C and annealed by cooling down to 
room temperature overnight. Prepared double-stranded probes were labeled with 
32P-γATP by incubating with the bacteriophage T4 polynucleotide kinase for 1 h. The 
labeling reaction was stopped by adding 2 µl EDTA (0.5 M, pH 8.0). The labeled probe 
was centrifuged in a Nick-spin-column for 2 minutes to remove non-bound 32P-γATP. 
The radioactivity of probe was measured in a ß-scintillation counter. 
For protein and probe interaction, in each reaction 5 µg nuclear protein extracts 
were mixed with 4 µl 5x binding buffer, 2 µl 10x proteinase inhibitor cocktail, 1 µl Poly 
dI:dC (1 µg/µl), 1 µl BSA (10 µg/µl), 32P labeled probe (30000 cpm per reaction) and 
H2O up to a final volume of 20 µl. In a control reaction protein was not added to the 
free probe. The reaction mixtures were incubated for 15 minutes at room temperature 
and further 15 minutes on ice. For super-shift-assays 1 µl antibody was added to a 
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reaction mixture, which was incubated for another 30 minutes on ice. The reaction 
was stopped with 2 µl loading buffer containing 20% Ficoll. Samples were loaded on a 
6% non-denaturating polyacrylamide gel and separated at 300 volt and 4°C for 
approximately 3 h. Afterwards the gel was fixed in 10% Acetic Acid; 20% Methanol for 
30 minutes and dried under vacuum at 80°C. At last the gel was exposed on x-ray film 
at -80°C and analyzed by autoradiography.    
 
Oligonucleotide sequences used for EMSA 
Name Sense (5´ - 3´) Antisense (5´ - 3´) 
cycAwt  TTCAATAGTCGCGGGATACTT  AAGTATCCCGCGACTACTATTGAA 
 
Reaction mix for 32P labeling 
Components Volume 
125 ng Oligonucleotide  in 3.3 µl 
10x T4-kinase buffer 2.0 µl 
T4-kinase 1.0 µl 
10 µCi/µl  32P-γATP  4 µl 
ddH2O 9.7 µl 
 
10x proteinase inhibitor cocktail 
Components Volume Final concentration 
Aprotinin solution  200 µl  
0.1 M Pefabloc 50 µl 50 mM 
1 M DTT 20 µl 20 mM 
ddH2O add 1 ml  
 
5x binding buffer 
Components 
125 mM HEPES, pH 7.6  
25 mM MgCl2 
170mM KCl  
 
5x TBE buffer 
Components 
45 mM Tris-base  
440 mM Boric acid 
1 mM EDTA, pH 8.0  
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6% EMSA gel  
Components Volume 
5x TBE   2.5 ml 
30% acrylamide 10 ml 
10% APS 350 µl 
TEMED 50µl 
ddH2O add 50 ml 
 
0.25x running buffer  
Components Volume 
5x TBE  75 ml 
ddH2O 1425 ml 
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3. Results 
3.1 Hepatocyte-specific ablation of Cdk2 does not affect liver 
regeneration after PH 
 
3.1.1 Analysis of G1/S transition and S-phase progression in Cdk2Δhepa 
mice  
 
To study the proliferative capacity of Cdk2-deficient hepatocytes, hepatocyte- 
specific conditional Cdk2 knockout mice (Cdk2Δhepa) were generated using the 
albumin-Cre/loxP system.  
 
Figure 3.1: Generation of hepatocyte-specific Cdk2 deletion in liver. (A) Gene-targeting 
strategy for creating hepatocyte-specific deletion of Cdk2. LoxP recombination sites were 
integrated in the introns 1 and 3 of the genomic Cdk2 locus (Ortega et al. 2003). Expression of 
cre-recombinase results in deletion of exons 2 and 3. (B) Cdk2 deletion efficiency in liver and 
isolated primary hepatocytes was measured by PCR with primers located in exons 1 and 4. 
The upper band specific for the wildtype locus is 465 base pairs (bp) in size and the lower 
band (255 bp) indicates Cdk2 knockout. 
 
1 2 3 4 5 6 7
ATG
loxP loxP
TGA
ATG TGA
loxP
1 4 5 6 7
Albuminpromoter Cre recombinase
A
B liver hepa
cre+-
Cdk2f/f
Cdk2∆
+-
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Cdk2loxP/loxP animals with two loxP sites flanking coding exons 2 and 3 were 
crossed with transgenic animals expressing cre-recombinase under the control of an 
Albumin/α-fetoprotein promoter/enhancer (Alfp-Cre) construct. In liver parenchymal 
cells the expression of albumin activates cre-recombinase, which excises exons 2 and 
3 from the Cdk2 gene (Figure 3.1 A). Excision of exons 2 and 3 in the Cdk2 locus 
causes a frame shift in the open reading frame of transcribed mRNA resulting in 
premature termination of protein translation. The truncated residual short polypeptide 
lacks Cdk2 function (Ortega et al. 2003). RT-PCR was performed to determine the 
Cdk2 deletion efficiency in liver and isolated primary hepatocytes. Nearly complete 
Cdk2 deletion was shown by RT-PCR with freshly isolated primary hepatocytes, while 
a slight residual signal for Cdk2 was still detectable in liver samples which can be 
explained by Cdk2 expression in non-parenchymal cells (Figure 3.1 B).  
To determine the effect of Cdk2 deletion in hepatocytes during liver regeneration, 
2/3 partial hepatectomy was performed in 7-8 weeks old Cdk2Δhepa mice and Cdk2f/f 
control animals. At different time points after PH, the mice were sacrificed and frozen 
cryosections were subjected to BrdU staining in order to determine the percentage of 
cells undergoing DNA-synthesis. Both groups showed identical kinetics of S-phase 
progression in the time course following PH (Figure 3.2 A-B). DNA synthesis started 
approximately 36 h after surgery and reached peak levels 48 h post PH. No significant 
differences between Cdk2f/f and Cdk2Δhepa mice were observed. In line with these 
findings, there was also no difference in the liver weight/body weight ratio between 
Cdk2Δhepa and Cdk2f/f animals at all investigated time points after PH (Figure 3.2C). 
These results indicate that Cdk2-deficient hepatocytes exhibit full potential to 
regenerate presumable through yet unknown compensatory proliferative mechanisms 
following liver dissection.  
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Figure 3.2: Hepatocyte-specific ablation of Cdk2 does not affect liver regeneration after 
PH. Cdk2f/f and Cdk2Δhepa mice were subjected to PH and sacrificed at indicated time points. 
Two hours before killing, all mice were injected with BrdU. (A) Immunofluorescence staining for 
BrdU incorporation on liver cryosections. BrdU positive signals located in nuclei were stained 
green by Alexa 488. Total nuclei were stained blue with DAPI. (B) Quantification of 
BrdU-positive hepatocytes in Cdk2f/f and Cdk2Δhepa mice. Data is calculated as percentage of 
BrdU-positive nuclei per magnification field. For each mouse at least 5-10 representative 
magnification fields were counted. Each value represents the mean of 5-10 mice. (C) Liver 
weight/body weight index (%) at indicated time points after PH. Data is presented as the 
average ± standard deviation (S.D.). 
 
3.1.2 Gene expression and protein regulation in Cdk2Δhepa mice during 
liver regeneration  
 
The previous experiment revealed that livers with Cdk2 deficiency exhibited 
normal restoration of both mass and function after PH. This was unexpected as Cdk2 
is believed to be an important factor for DNA replication. However, the underlying 
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mechanisms for compensating the loss of Cdk2 at a molecular level remained 
unknown. Thus, the effect of Cdk2 deficiency on gene expression and protein 
regulation of other cell cycle related genes involved in G1/S-phase transition in 
quiescent liver as well as in regenerating liver was further investigated by qPCR and 
western blot analysis. Interestingly, basal gene expression of CcnD1 was 
approximately 2.5 fold increased in Cdk2Δhepa livers and CcnE1 expression was also 
slightly but significantly elevated in these mice. In contrast, basal gene expression of 
the second E-type cyclin (CcnE2) was not enhanced in Cdk2Δhepa livers (Figure 3.3 A). 
In accordance with higher CcnD1 mRNA levels, western blot analysis confirmed weak 
basal expression of CcnD1 protein in quiescent liver but also in primary hepatocytes 
of Cdk2Δhepa mice after prolonged exposition (Figure 3.3 B). Of notice, expression of 
cell cycle inhibitors such as p16, p21 and p27 was not affected by the loss of Cdk2 in 
quiescent Cdk2Δhepa livers. These data suggest that quiescent Cdk2-deficient 
hepatocytes are unexpectedly predisposed to G0/G1-S-phase transition via 
aberrantly higher CcnD1 and CcnE1 expression. 
 
Figure 3.3: Depletion of Cdk2 results in basal over-expression of CcnD1 and CcnE1. 
Livers and primary hepatocytes of untreated Cdk2f/f and Cdk2Δhepa mice were investigated for 
gene- and protein expression of indicated cell cycle mediators. (A) qPCR analysis of CcnD1, 
CcnE1 and CcnE2 in livers from 7-8 weeks old Cdk2f/f and Cdk2Δhepa mice. (B) Western blot 
analysis of CcnD1, p16, p21 and p27 protein expression. Two independent livers per group 
and cell lysates from primary hepatocytes were used. The expression level of GAPDH is 
presented as internal loading control. Data is presented as the average ± S.D. *: p< 0.05; **: 
p<0.01. 
 
To further analyze the consequences of Cdk2-deficiency on cell cycle signaling 
during liver regeneration, expression profiles of CcnE1, CcnE2 and its transcriptional 
activator E2F1 were determined in Cdk2f/f and Cdk2Δhepa mice at important time points 
after PH. In accordance with its slightly increased basal expression, CcnE1 showed 
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an accelerated induction and premature down-regulation in Cdk2Δhepa livers compared 
to WT controls (Figure 3.4 A). In contrast, CcnE2 and E2F1 were similarly induced in 
Cdk2Δhepa and Cdk2f/f mice, but also showed earlier down-regulation in liver of 
Cdk2Δhepa mice (Figure 3.4 B-C). These data suggest that accelerated induction of 
CcnE1 is largely independent of its prototypical transcriptional activator E2F1. 
 
Figure 3.4: Depletion of Cdk2 results in earlier induction of CcnE1 and premature 
down-regulation of CcnE1, CcnE2 and E2F1. (A-C) Gene expression profiles of CcnE1, 
CcnE2 and E2F1 were determined in Cdk2f/f and Cdk2Δhepa mice at 0-96 h post PH by qPCR. 
For each time point, 3-5 animals were analyzed. Data is presented as the average ± S.D.     
*: p< 0.05.  
 
Consistent with these data, western blot analysis for CcnE1 expression revealed 
accelerated induction in Cdk2Δhepa livers as well, which was first detectable already  
36 h post PH (Figure 3.5). Furthermore, slightly increased CcnD1 gene expression in 
Cdk2Δhepa mice 48 and 72 h after PH could be detected on the protein level correlating 
with slightly elevated protein levels of Cdk4 and Cdk6. Of notice, protein expression of 
CcnA2 and Cdk1 - indicative of S-phase progression and G2/M-transition - was 
similar in both groups (Figure 3.5). Proliferating cell nuclear antigen (PCNA) is a 
nuclear protein involved in initiating DNA synthesis (Theocharis et al. 1994). 
Interestingly, western blot analysis revealed overall stronger up-regulation of PCNA 
between 36-72 h after PH in Cdk2Δhepa mice indicating that Cdk2 depletion does not 
inhibit, but rather supports G1/S-phase initiation (Figure 3.5).  
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Figure 3.5: Depletion of Cdk2 results in moderately elevated protein levels of interphase 
cyclins (CcnD1 and CcnE1), Cdks (Cdk4 and Cdk6) and PCNA. Protein expression profiles 
of CcnD1, CcnE, CcnA2, Cdk4, Cdk6 and Cdk1 in Cdk2f/f and Cdk2Δhepa mice at 0-72 h post 
PH are shown. GAPDH expression was used as internal loading control. 
 
3.1.3 Identification of compensatory kinase activities in absence of Cdk2 
 
The canonical role of CcnE involves association with Cdk2 and formation of an 
active kinase complex capable of phosphorylating substrates. As a central regulator of 
G1/S transition, the Cdk2/CcnE complexes play multiple roles on cell cycle events 
including DNA replication and centrosome duplication. One key event of G1/S 
transition is phosphorylation of the pocket protein Rb via Cdk2/CcnE complexes. Rb 
phosphorylation was first detectable 36 h after PH and reached the peak level 48 h 
after surgery in both Cdk2f/f and Cdk2Δhepa animals (Figure 3.6 A). These similar 
expression profiles in both groups were unexpected and hint at the existence of an 
additional kinase activity (or activities) in Cdk2Δhepa mice which can compensate loss 
of Cdk2. To identify this kinase (or these kinases), kinase activities of known G1 and 
S-phase Cdk/cyclin complexes involved in cell cycle regulation were systematically 
examined in quiescent (0 h) and regenerating livers (36-48 h after PH, Figure 3.6 B). 
As expected, Cdk2-related kinase activity could not be detected at all in Cdk2Δhepa 
mice. In contrast, the experiment revealed an elevated kinase activity of 
CcnD1-related complexes (CcnD1/Cdk4 and CcnD1/Cdk6) 36 h after PH in Cdk2Δhepa 
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mice, which correlates with slightly enhanced gene expression of CcnD1, Cdk4 and 
Cdk6 (compare with figure 3.5). Furthermore, Cdk1 exhibited enhanced activity 48 h 
after PH in Cdk2Δhepa mice compared to controls, which indicates that loss of Cdk2 at 
this time point could be compensated by Cdk1. One canonical binding partner of both 
Cdk1 and Cdk2 is CcnA2. However, in vitro kinase assays revealed that 
CcnA2-related kinase activities were substantially reduced in Cdk2Δhepa mice (Figure 
3.6 B). Thus, it is unlikely that Cdk1/CcnA2 alone compensates for loss of Cdk2.  
Earlier studies demonstrated that CcnE1 can also associate with Cdk1 in 
absence of Cdk2 in embryo, spleen and thymus (Aleem et al. 2005; Santamaria et al. 
2007). However, the present results clearly showed that none of the E-type cyclins 
form any compensatory kinase activity during liver regeneration in Cdk2Δhepa mice. 
Taken together, this experiment demonstrated that lack of Cdk2 kinase is very likely 
compensated by CcnD1/Cdk4/Cdk6 at 36 h and substituted by Cdk1 at 48 h after PH. 
 
Figure 3.6: Cdk2 deficiency in liver is compensated by alternative Cdk/cyclin complexes. 
(A) Phosphorylation of Rb in Cdk2f/f and Cdk2Δhepa mice at 0-96 h post PH was determined by 
western blot analysis. (B) Cdk2f/f and Cdk2∆hepa mice were subjected to PH. At time points after 
PH as indicated, liver extracts were subjected to immunoprecipitation (IP) with antibodies 
directed against Cdks and cyclins. Precipitated Cdk/cyclin complexes were used for in vitro 
kinase assays using recombinant histone H1 (H1) or Rb as substrate. Phosphorylated proteins 
are highlighted by arrows. 
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3.2 Hepatocyte proliferation and liver regeneration can be inhibited 
by application of the Cdk-inhibitor Roscovitine 
 
The previous data revealed that genetic loss of Cdk2 in hepatocytes was not 
sufficient to block the proliferation of hepatocytes after PH. With regard to the 
anticipated important role of Cdk2 for the cell cycle, these findings were largely 
unexpected and thus should be further investigated using an independent 
pharmacological approach.  
 
3.2.1 Roscovitine effectively blocks DNA-synthesis during liver 
regeneration 
 
The low molecular inhibitor Roscovitine predominantly inhibits Cdk2 but also 
Cdk1 and to a lesser extend Cdk7 and Cdk9 (Nutley et al. 2005). To determine the 
inhibitory effect of Roscovitine on DNA-synthesis during liver regeneration, mice were 
injected with Roscovitine 2 times after PH according to the scheme in Figure 3.7 A. 
Roscovitine treatment significantly diminished DNA-synthesis 48 h after PH in 
WT mice (Figure 3.7 B-C). However, Roscovitine-treated mice rather showed a 
delayed proliferation peak than a complete proliferation block, since a significantly 
higher percentage of BrdU positive cells was observed 72 h after PH in 
Roscovitine-treated mice indicating that the effect of Roscovitine was reversible. 
Roscovitine completely blocked both Cdk2 and Cdk1 kinase activities in regenerating 
mice 48 h after PH (Figure 3.7 D). Delayed DNA-synthesis in Roscovitine-treated 
mice appearing 72 h post-surgery correlated with full restoration of Cdk1 kinase 
activity and slight activation of Cdk2.  
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Figure 3.7: Roscovitine effectively blocks DNA-synthesis in the regenerating liver. (A) 
Experimental setting: WT mice were subjected to PH. Twenty-eight and 40 h after surgery, 
Roscovitine (or DMSO as solvent control) was administered i.p. at a concentration of 50 mg/kg. 
Mice were sacrificed 48 h and 72 h after PH, respectively. (B) Immunofluorescence staining for 
BrdU-positive hepatocytes (stained in green) on liver cryosections at 48 and 72 h after PH in 
WT mice treated with DMSO or Roscovitine. (C) Quantification of BrdU-positive hepatocytes in 
DMSO or Roscovitine-treated mice. Data is calculated as percentage of BrdU-positive nuclei 
per magnification field. Each value represents the mean of 3-5 mice. For each mouse at least 
5-10 representative magnification fields were counted. **: p<0.01. (D) Native Cdk2 and Cdk1 
complexes were immunoprecipitated (IP) with indicated antibodies from WT livers at 48 and 
72h after PH and Roscovitine/DMSO treatment and then subjected to histone H1 kinase 
assays. Phosphorylation of H1 (p-H1) is highlighted by arrows. 
 
To further dissect the contribution of Cdk2 and Cdk1 for S-phase progression in 
the liver, the same experimental settings (PH and Roscovitine treatment) were applied 
to Cdk2Δhepa mice. Interestingly, Roscovitine application inhibited DNA-synthesis in 
WT and Cdk2Δhepa animals to the same extend (Figure 3.8 A). This strongly suggests 
that the inhibitory effect of Roscovitine on DNA-synthesis is independent of Cdk2 and 
rather mediated via blocking both Cdk2 and Cdk1.  
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 Results  
Roscovitine (Figure 3.8 B). In Cdk2Δhepa mice even slightly elevated protein levels of 
CcnE were observed. Taken together, these data suggest that Roscovitine inhibits 
DNA-synthesis in an E2F-Rb dependent manner by blocking Cdk2 and Cdk1. 
 
3.2.2 Over-expression of CcnE1 rescued CcnA2 gene expression and Rb 
phosphorylation in Roscovitine treated primary hepatocytes  
 
The previous data indicates that Roscovitine inhibits DNA-synthesis of the 
proliferating liver via blocking both Cdk2 and Cdk1 activities. Moreover, genetic 
inactivation of CcnE2 results in over-expression of CcnE1 and accelerated S-phase 
initiation after PH (Nevzorova et al. 2009). Due to this over-expression of CcnE1, 
Roscovitine treatment induced slight reduction of DNA-synthesis after PH in CcnE2-/- 
mice rather than blocked strongly S-phase progression as shown in WT mice 
(Nevzorova, personal communication). With regard to tumorigenesis, CcnE1 
over-expression was frequently observed in cancer cells and could contribute to 
carcinogenesis (Hwang and Clurman 2005). Thus, it is of high interest to test if 
over-expression of CcnE1 expression can partially rescue hepatocyte proliferation 
after Roscovitine-mediated inhibition of Cdk1 and Cdk2. Using an adenoviral 
approach CcnE1 was over-expressed in mitogen stimulated primary WT hepatocytes 
(Figure 3.9 A). Thereafter hepatocytes were transiently treated with Roscovitine. After 
two days, control cells entered S-phase as indicated by onset of CcnA2 expression 
and Rb phosphorylation, which was strongly inhibited by Roscovitine treatment 
(Figure 3.9 B). However, adenoviral over-expression of CcnE1 partially rescued the 
Roscovitine-mediated S-phase arrest demonstrating that CcnE1 over-expression 
facilitates G1/S transition even when the most, if not all, kinase activities of Cdk1 and 
Cdk2 are inhibited. 
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Figure 3.9: Adenoviral CcnE1 over-expression can partially rescue the Roscovitine- 
mediated cell cycle inhibition. (A) Primary hepatocytes from WT mice were isolated and 
transduced with a luciferase control adenovirus (Ctrl) or a bicistronic adenovirus expressing 
CcnE1 and GFP (CcnE1). Adv-CcnE1 transduction efficiency was determined by fluorescence 
microscopy 24 h post transfection. Infected hepatocytes appear in green; total number of 
plated cell was in parallel visualized by light microscopy. (B) Primary hepatocytes were 
stimulated with mitogen EGF and insulin 16 h after transfection. 24 h after virus infection, cells 
were transiently stimulated with Roscovitine or DMSO for 4 h and harvested 48 h after initial 
adenoviral infection. As marker for S-phase progression the expression of CcnA2 and 
phosphorylated Rb (pRb) was determined by western blot analysis. n.s.: non-specific signal. 
 
3.3 CcnE1 plays an essential role for MCM2 loading on pre-RC and 
CcnA2 regulation in Cdk2Δhepa mice 
 
3.3.1 Cdk2-deficiency in hepatocytes is associated with premature 
pre-RC formation involving CcnE1 
 
The previous experiments identified potential compensatory Cdk/cyclin 
complexes, which revealed enhanced activity during liver regeneration in absence of 
Cdk2. However, it was completely unexpected that CcnE1 was over-expressed in 
Cdk2∆hepa liver at early liver regeneration (36 h post PH, Figure 3.4 A), but did not 
contribute to any non-canonical Cdk kinase activity (Figure 3.6 B). This was especially 
surprising as E-cyclins are essential for G0/G1-S-phase transition at least in 
embryonic fibroblasts (Geng et al. 2003). Additional evidence suggests a 
non-canonical function of E-cyclins in formation of the pre-replicative (pre-RC) 
complex, which is kinase-independent (Geng et al. 2007).  
Therefore, in the present study it was hypothesized that CcnE1 holds a 
Cdk2-independent function during liver regeneration in absence of Cdk2 involving 
pre-RC complex formation. To address this hypothesis, the expression and 
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localization of replication-related factors such as PCNA, CcnE1, MCM2 and Cdt1 was 
further investigated in mitogen-stimulated primary hepatocytes in vitro. In comparison 
to WT cells, PCNA expression was induced one day earlier (day 2 after plating) in 
Cdk2-deficient hepatocytes, which was correlated with accelerated onset of CcnE1 
expression. In addition, peak expression of MCM2 appeared also earlier in Cdk2Δhepa 
cells (Figure 3.10 A). In line with these findings in Cdk2Δhepa hepatocytes, the amount 
of chromatin-bound CcnE1 was also increased in these cells after two days of 
culturing. Higher CcnE1 level in chromatin-bound fraction correlated with increased 
MCM2-loading on chromatin in Cdk2Δhepa hepatocytes (Figure 3.10 B). Moreover, in 
the absence of Cdk2, CcnE1 constitutively interacted with Cdt1 as demonstrated by 
co-immunoprecipitation experiments (Figure 3.10 C). Physical interaction of CcnE1 
with Cdt1 might facilitate the loading of MCM2 at Pre-RC (Geng et al. 2007). These 
data suggests that up-regulation of CcnE1 in Cdk2-deficient cells results in earlier 
pre-RC formation.  
 
Figure 3.10: CcnE1 is overexpressed in Cdk2-deficient primary hepatocytes and shows 
accelerated co-localization with MCM2 and Cdt1 at chromatin. Primary mouse 
hepatocytes from Cdk2f/f and Cdk2Δhepa mice were isolated and cultured for up to 3 days in the 
presence of the mitogenic stimuli EGF and insulin. (A) Western blots showed protein 
expression of PCNA, CcnE1 and MCM2. GAPDH expression was determined as internal 
loading control. (B) The expression and cellular localization of MCM2, CcnE1 and Cdk2 were 
analyzed by western blot using fractionated cell extracts representing whole free cytoplasmic 
protein proteins (free) or the chromatin-bound proteins, respectively. TATA binding protein 
(TBP) and GAPDH represent loading controls for chromatin-bound and free fractions, 
respectively. (C) CcnE1 complexes were isolated from total proteins by immunoprecipitation 
(IP: CcnE1) and probed for Cdt1, CcnE1 and Cdk2 by western blot analysis. 
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3.3.2 Additional depletion of CcnE1 in Cdk2Δhepa hepatocytes markedly 
reduces MCM2 loading 
 
The data from Cdk2Δhepa mice emphasize an essential kinase-independent role of 
CcnE1 in hepatocyte proliferation in a Cdk2 deficient background, especially in the 
loading of MCM2 complexes at pre-RC.This leads to the hypothesis that hepatocytes 
with deletion of both Cdk2 and CcnE1 genes might have a defect in MCM2 loading, 
which could impair DNA-synthesis. To test this hypothesis, Cdk2ΔhepaCcnE1-/- double 
knockout mice were generated by crossing Cdk2Δhepa mice with mice constitutively 
lacking CcnE1 (CcnE1-/-). The latter ones were recently shown to have only a minor 
effect on hepatocyte proliferation after PH (Nevzorova et al. 2009). Briefly, CcnE1-/- 
mice showed a slight delay in S-phase entry but otherwise normal DNA synthesis and 
liver regeneration after partial hepatectomy.  
Cdk2ΔhepaCcnE1-/- mice did not show any abnormality during embryonic and 
postnatal development (data not shown). Primary hepatocytes of 7–8 weeks old 
Cdk2ΔhepaCcnE1-/- mice were isolated and cultured in the presence of mitogenic 
stimulation. After two days culturing, a strong reduction of MCM2 level in both the 
chromatin fraction and the free fraction was observed compared to WT or Cdk2Δhepa 
hepatocytes (Figure 3.11). Collectively, these data indicated that a Cdk2-independent 
function of CcnE1 is essential for the loading of MCM2 at chromatin at least in the 
absence of Cdk2.  
 
Figure 3.11: Combined depletion of Cdk2 and CcnE1 in hepatocytes results in reduced 
MCM2 loading on chromatin. Primary mouse hepatocytes from WT, Cdk2Δhepa and 
Cdk2ΔhepaCcnE1-/- mice were isolated and cultured for 2 days in the presence of the mitogenic 
stimuli EGF and insulin. The expression and cellular localization of MCM2 and CcnE1 were 
analyzed by western blot using fractionated cell extracts representing whole cytoplasmic 
protein (free) or the chromatin-bound proteins, respectively. TATA binding protein (TBP) and 
GAPDH represent loading controls for chromatin- and cytoplasmic fractions, respectively. 
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3.3.3 CcnE1 is essential for driving CcnA2 gene expression in 
Cdk2-deficient hepatocytes  
 
To further characterize the consequences of combined Cdk2 and CcnE1 ablation 
for DNA synthesis and hepatocyte proliferation, the expression of CcnA2 (indicative of 
S-phase progression) was determined. Results from qRT-PCR and western blot 
analysis clearly demonstrated that additional depletion of CcnE1 in Cdk2Δhepa cells 
substantially inhibited CcnA2 gene expression (Figure 3.12 A-B). Thus, in absence of 
Cdk2, expression of CcnE1 is imperative for CcnA2 gene and protein expression in 
hepatocytes.  
 
Figure 3.12: Combined depletion of Cdk2 and CcnE1 results in strongly reduced CcnA2 
expression. Primary mouse hepatocytes from WT, Cdk2Δhepa and Cdk2ΔhepaCcnE1-/- mice 
were isolated and cultured for up to 3 days in the presence of the mitogenic stimuli EGF and 
insulin. (A) qPCR analysis of CcnA2 gene expression. Data is calculated as fold induction in 
comparison to untreated WT cells and normalized using GAPDH expression as internal 
standard. Data is presented as the average ± S.D. *: p<0.05; **: p<0.01; ***: p<0.001. (B) 
Western blot analysis of CcnA2 protein expression in WT and Cdk2ΔhepaCcnE1-/- hepatocytes 
three days after plating (D3). 
 
During G1/S transition, onset of CcnE expression is followed by induction of 
CcnA2 gene expression in an E2F-dependent manner. Previous studies 
demonstrated that the Cdk2/CcnE complex can directly associate with E2F/p107 
transcription factors bound to an E2F binding site located in the CcnA2 promoter 
resulting in transactivation of CcnA2 gene expression (Schulze et al. 1995; 
Zerfass-Thome et al. 1997). To further analyze the function of CcnE1 on CcnA2 
promoter regulation, EMSA analysis was performed using nuclear proteins from WT 
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and Cdk2ΔhepaCcnE1-/- hepatocytes and a double-stranded probe containing a 
documented E2F binding site derived from the WT murine CcnA2 promoter. The 
experiment revealed two protein/DNA complexes (I and II) with low mobility in WT 
samples which accumulated with time and CcnA2 expression (Figure 3.13; also 
compare Figure 3.12 for CcnA2 expression profile). In sharp contrast, complex I and II 
were barely detectable in proteins from Cdk2ΔhepaCcnE1-/- hepatocytes at any time 
point investigated. These data suggests that simultaneous loss of CcnE1 and Cdk2 
inhibits the association of a trans-activating E2F protein complex at the CcnA2 
promoter. 
 
Figure 3.13: Combined depletion of Cdk2 and CcnE1 results in reduced protein binding 
to CcnA2 promoter. Primary hepatocytes from WT and Cdk2ΔhepaCcnE1-/- mice were isolated 
and cultured for up to 3 days (D0 – D3) in the presence of the mitogenic stimuli EGF and 
insulin. At time points indicated, nuclear proteins were isolated from hepatocytes. 5 µg nuclear 
proteins per sample were subjected to EMSA. In the first lane (free oligo) the oligonucleotide 
was loaded without adding protein. The signal specific for unbound probe with high mobility is 
shown as a loading control. I: complex I binding to probe; II: complex II binding to probe. 
 
3.3.4 Combined deletion of Cdk2 and CcnE1 impairs DNA-synthesis and 
proliferation of primary hepatocytes 
 
CcnA2 promotes S-phase progression and S/G2-M phase transition by 
association with either Cdk2 or Cdk1, respectively (Chibazakura et al. ; Copeland et 
al. ; Sherr and Roberts 2004). Thus, impaired CcnA2 gene expression as well as the 
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defect in MCM2 loading at the pre-RC, which was observed in Cdk2ΔhepaCcnE1-/- 
hepatocytes could affect S-phase entry and subsequent DNA synthesis. To test this 
hypothesis, DNA-synthesis in primary hepatocytes from Cdk2ΔhepaCcnE1-/- mice and 
WT controls was determined by in vitro BrdU incorporation assay. After one day of 
culturing (D1), no BrdU positive cells were observed in Cdk2ΔhepaCcnE1-/- cells, while 
very few BrdU positive cells were detectable in WT and Cdk2Δhepa hepatocytes. In the 
subsequent two days of cell culture WT or Cdk2Δhepa hepatocytes showed a 
substantial induction of DNA synthesis which peaked at day 3 (D3) after plating, while 
Cdk2ΔhepaCcnE1-/- hepatocytes had strongly reduced S-phase reflecting approximately 
50% BrdU incorporation compared to controls at day 2 and only 25% of controls at 
day 3 after plating (Figure 3.14 A-B).  
 
Figure 3.14: Combined depletion of Cdk2 and CcnE1 results in impaired DNA-synthesis. 
Primary hepatocytes from WT, Cdk2Δhepa and Cdk2ΔhepaCcnE1-/- mice were isolated and 
cultured for up to 3 days on collagen coated cover slips. Two hours before cells were 
harvested, 20 µM BrdU were supplied to cell medium. (A) Immunofluorescence staining for 
BrdU incorporation. Nuclei with BrdU incorporation in newly synthesized DNA are stained in 
green. Total nuclei are counter-stained with DAPI (blue). (B) Quantification of BrdU-positive 
hepatocytes. Data is calculated as percentage of BrdU-positive nuclei per magnification field. 
Data is presented as the average ± S.D. *: p<0.05; ***: p<0.001. 
 
These data clearly demonstrated that hepatocytes without CcnE1 and Cdk2 and 
subsequent low levels of CcnA2 have a severe defect in DNA-replication. In addition, 
light microscopy analysis demonstrated that Cdk2ΔhepaCcnE1-/- hepatocytes displayed 
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massive reduction of cell density over time indicating severely impaired viability and 
induction of cell death (Figure 3.15 A-B).  
 
Figure 3.15: Hepatocytes lacking Cdk2 and CcnE1 display severely impaired viability. 
Primary hepatocytes from WT and Cdk2ΔhepaCcnE1-/- mice were isolated and cultured for up to 
3 days in the presence of mitogenic stimuli (EGF, insulin). (A) Microscopic images of cultured 
hepatocytes. D0 is defined as the day following cell plating; D3: hepatocytes three days after 
plating. (B) Quantification of hepatocytes per magnification field. For each mouse at least 10 
representative magnification fields were counted. Cell numbers were normalized to the 
average cell numbers determined at D0. Data is presented as the mean ± standard deviation. 
**: p < 0.01. 
 
To confirm the finding that Cdk2ΔhepaCcnE1-/- hepatocytes have reduced 
DNA-synthesis and increased cell death, flow cytometry of propidium iodide stained 
primary hepatocytes was performed to determine the DNA content. In sharp contrast 
to WT hepatocytes, a large population (approximately 50%) of Cdk2ΔhepaCcnE1-/- cells 
showed a DNA content which was lower than typically found in diploid resting cells 
(2n). This cell population is usually referred to as sub-G1 population and reflects 
mostly apoptotic cells with DNA degradation. Moreover, the WT cells contained 
approximately 2 times more diploid hepatocytes (2n) and 3 times more tetraploid 
hepatocytes (4n) compared to Cdk2ΔhepaCcnE1-/- cells (Figure 3.16 A-B). The 
difference in cell populations having octoploidy (8n) and hyperploidy (>8n) was not 
significant between two groups. These data clearly confirmed that 
Cdk2/CcnE1-deficient hepatocytes are almost completely devoid of DNA replication 
and highly prone to apoptosis. 
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hepatocytes might originate from cell fusion. To test this possibility, Cdk2ΔhepaCcnE1-/- 
hepatocytes were isolated from both female and male mice, mixed in a 1:1 ratio, and 
cultured for up to 3 days on cover slips. Each remaining hepatocyte was then 
examined for presence of Y-chromosomes by Fluorescence in situ Hybridization 
(FISH). In fact, many polynuclear giant cells containing both Y-chromosome-positive 
nuclei (derived from male hepatocytes) and Y-chromosome-negative nuclei (derived 
from female hepatocytes) were detected (Figure 3.17). This observation suggests that 
Cdk2ΔhepaCcnE1-/- hepatocytes tend to cell fusion with adjacent cells under in vitro 
conditions. However, the physiological relevance of the cell fusion mechanism in this 
scenario is still unknown and will not be further investigated as a part of this study. 
 
Figure 3.17: Primary hepatocytes lacking Cdk2 and CcnE1 frequently undergo cell 
fusion resulting in polynuclear giant cells. Primary hepatocytes from female and male 
Cdk2ΔhepaCcnE1-/- mice were mixed in a 1:1 ratio and cultured for up to 3 days on collagen 
coated cover slips. Y-chromosomes are stained by specific Y-chromosome painting probe (red 
signals). Nuclei are stained blue by DAPI. Green autofluorescence of hepatocytes is used to 
identify individual single cells. 
 
3.4 Combined ablation of Cdk2 and CcnE1 in vivo impairs liver 
regeneration after PH 
 
3.4.1 Analysis of G1/S transition and S-phase progression in livers of 
Cdk2Δhepa CcnE1-/- mice after PH 
 
The previous in vitro experiments clearly demonstrated that an additional deletion 
of CcnE1 in Cdk2Δhepa mice prevents MCM2 loading at pre-replication complexes and 
inhibits CcnA2 transcription in ex vivo isolated hepatocytes leading to impaired 
DNA-synthesis and cell viability. Therefore it is of high interest to investigate if 
proliferation of hepatocytes lacking CcnE1 and Cdk2 is also prevented in the liver 
regeneration model. Thus, 7-8 weeks old Cdk2ΔhepaCcnE1-/- mice as well as WT 
controls were subjected to 70% partial hepatectomy. BrdU staining revealed that livers 
of Cdk2ΔhepaCcnE1-/- mice showed dramatically reduced DNA synthesis 40-48 h after 
DAPI Y-chromosome Autofluorescence Merge
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PH (Figure 3.18 A-B) which is in good agreement with the previous findings in vitro.  
As a consequence of reduced DNA-synthesis, Cdk2ΔhepaCcnE1-/- mice showed a 
significantly reduced liver weight/body weight ratio 7 days after surgery which 
demonstrates that liver regeneration is inefficient after simultaneous loss of CcnE1 
and Cdk2 (Figure 3.18 C). However all Cdk2ΔhepaCcnE1-/- mice survived the surgery 
and were viable for at least one month after PH (data not shown). 
 
Figure 3.18: Simultaneous genetic ablation of Cdk2 and CcnE1 in hepatocytes 
substantially impairs DNA-synthesis of hepatocytes and liver regeneration after PH. WT 
and Cdk2ΔhepaCcnE1-/- mice were subjected to PH. Remnant livers were analyzed at 0-168 h 
after surgery. (A) Immunofluorescence staining for BrdU incorporation on liver cryosections. 
BrdU positive signals located in nuclei are stained in green. Total nuclei are counter-stained 
with DAPI (blue). (B) Quantification of BrdU-positive hepatocytes. Data is calculated as 
percentage of BrdU-positive nuclei per magnification field. For each mouse at least 5-10 
representative magnification fields were counted. Each value represents the mean of 5-10 
mice. (C) Liver weight/body weight index (%) at indicated time points after PH. Data is 
presented as the mean ± standard deviation. 
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Alanine-aminotransferase (ALT) and aspartate-aminotransferase (AST) are liver 
enzymes, which are activated upon liver damage and are thus established serum 
markers for the quantification of liver injury. To test if impaired liver regeneration in 
Cdk2ΔhepaCcnE1-/- mice resulted in enhanced liver damage, AST and ALT values were 
measured at different time points after PH. However, in comparison to controls no 
elevation in transaminase activity was detected in serum of Cdk2ΔhepaCcnE1-/- mice 
40-48 h post-surgery (Figure 3.19 A) as well as 7 days after PH. This observation was 
in part unexpected and is in contradiction to the poor viability of ex vivo isolated 
Cdk2ΔhepaCcnE1-/- hepatocytes (compare Figure 3.15). 
In line with this finding, Cdk2ΔhepaCcnE1-/- livers did not show aberrantly enhanced 
apoptosis 40 h and 48 h after PH as evidenced by TUNEL analysis (Figure 3.19 C). 
Instead, both groups revealed only few apoptotic liver cells after PH suggesting that 
apoptosis plays only a minor role in the progression phase of liver regeneration.  
 
Figure 3.19: Liver damage after PH is not aggravated by concomitant ablation of CcnE1 
and Cdk2. WT and Cdk2ΔhepaCcnE1-/- mice were subjected to PH. (A) AST level and (B) ALT 
level in serum were measured at time points indicated. Each bar represents an average value 
of 5 animals. Data is presented as the mean ± standard deviation. (C) Representative images 
of TUNEL staining on liver cryosections from WT and Cdk2ΔhepaCcnE1-/- mice 48 h after PH. 
Nuclei are stained blue by DAPI and apoptotic cells are stained green. 
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In comparison to WT hepatocytes, cells lacking CcnE1 and Cdk2 showed an 
overall enlargement in cell size, which was statistically significant. In addition, 
Cdk2ΔhepaCcnE1-/- livers showed a lower density of nuclei after liver regeneration. 
These data suggests that in Cdk2ΔhepaCcnE1-/- livers normal liver function is restored 
at least in part by hypertrophy of hepatocytes and to a lesser extent by cell division 
hinting at an alternative mechanism for liver regeneration. 
Hypertrophic enlargement of cells is closely correlated with activity of RNA 
polymerase III, which produces transfer RNAs, 5S ribosomal RNA and several other 
un-translated RNAs thereby enhancing translational capacity (Goodfellow and White 
2007). To further examine the hypertrophic status of Cdk2ΔhepaCcnE1-/- cells at the 
molecular level, gene expression of 7SL ribosomal RNA (White 2004), which is a 
product of RNA polymerase III, was determined (Figure 3.21). Interestingly, basal 7SL 
expression in Cdk2ΔhepaCcnE1-/- mice was already two times higher compared to WT 
animals. Seven days after surgery (termination of liver regeneration in WT mice), 
expression level of 7SL in Cdk2ΔhepaCcnE1-/- liver was still two times higher than in WT 
liver indicating that combined loss of Cdk2 and CcnE1 constitutively triggers a 
stronger metabolic capacity in the liver.  
 
Figure 3.21: Hypertrophy of Cdk2ΔhepaCcnE1-/- liver is associated with high activity of 
mRNA polymerase III. Gene expression of 7SL in untreated liver and regenerated liver 168 h 
post PH from WT and Cdk2ΔhepaCcnE1-/- mice. For each group, 5 animals (7-9 weeks old) were 
analyzed. Data is presented as the mean ± standard deviation. **: p<0.01; ***: p<0.001. 
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 Results  
3.4.3 Molecular analysis of cell cycle signaling in Cdk2ΔhepaCcnE1-/- mice 
after PH 
 
In order to understand the underlying molecular mechanisms resulting in partial 
inhibition of DNA-synthesis and impaired liver regeneration in Cdk2ΔhepaCcnE1-/- mice, 
the expression of several cell cycle regulators was systematically investigated at the 
protein level. Liver samples of hepatectomized mice at different investigated time 
points were subjected to western blot analysis (Figure 3.22). As expected, CcnE1 was 
not detected at all in Cdk2ΔhepaCcnE1-/- liver. In accordance with the data obtained 
from in vitro experiments (Figure 3.12), the CcnA2 protein expression was also 
strongly reduced in Cdk2ΔhepaCcnE1-/- mice compared to WT animals 48 h after PH, 
which reflects the peak of DNA-synthesis in WT liver. Moreover, CcnB1 protein 
expression, which is essential for mitosis, was induced 48 h after PH in WT controls 
but barely detectable in Cdk2ΔhepaCcnE1-/- liver. This implies that inhibition of 
DNA-synthesis could also indirectly block mitosis. Of notice, PCNA was normally 
regulated post PH in Cdk2ΔhepaCcnE1-/- liver suggesting that PCNA expression is 
regulated upstream of Cdk2/CcnE1 and thus not affected by the deletion of Cdk2 or 
CcnE1. 
 
Figure 3.22: Combined depletion of CcnE1 and Cdk2 inhibits protein expression of 
CcnA2 and CcnB1 and prevents Rb phosphorylation. Protein expression profiles of 
phospho-Rb, CcnE1, CcnA2, CcnB1 and PCNA in WT and Cdk2ΔhepaCcnE1-/- mice at 0-72 h 
post PH. GAPDH was used as loading control. 
 
The previous data demonstrated that in absence of Cdk2 alone Rb is still 
completely phosphorylated following PH presumably via a CcnD1 related kinase 
activity 36 h post PH and by Cdk1 kinase activity (e.g. Cdk1/CcnA2 kinase) 48 h post 
PH (compare Figure 3.6). In Cdk2ΔhepaCcnE1-/- liver, CcnA2 expression was strongly 
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reduced. Accordingly, CcnA2 kinase activity was also substantially impaired 48 h after 
PH (Figure 3.23). Concomitantly with this, the kinase activity of Cdk1 was also 
markedly reduced 48 h after PH supporting the hypothesis that Cdk1/CcnA2 complex 
may compensate the loss of Cdk2 in Cdk2Δhepa liver 48 h after PH which is no longer 
possible in Cdk2ΔhepaCcnE1-/- liver due to impaired CcnA2 expression. In line with this 
data Rb phosphorylation was also reduced 48 h after PH (Figure 3.22). Systematic 
examination of kinase activities also revealed that Rb phosphorylation 36 h after PH 
was most likely executed by CcnD related kinase complexes in Cdk2ΔhepaCcnE1-/- liver, 
which was comparable to data in Cdk2Δhepa mice after PH. Taken together, in 
Cdk2ΔhepaCcnE1-/- liver the loss of Cdk2 kinase activity is not fully compensated by 
another kinase presumably due to lack of sufficient CcnA2 expression. 
 
Figure 3.23: Additional deletion of CcnE1 in a Cdk2-deficient background represses the 
compensatory Cdk1/CcnA2 kinase activity. Whole liver cell extracts were collected from 
WT and Cdk2ΔhepaCcnE1-/- mice at indicated time points after PH. Native Cdk/cyclin kinase 
complexes were immunoprecipitated (IP) with antibodies as indicated and subjected to in vitro 
kinase assays using either recombinant Rb or histone H1 as substrate. Signals indicating 
phosphorylation are highlighted by arrows. 
 
3.4.4 Contribution of non-parenchyma cells to liver regeneration 
 
The use of Cdk2ΔhepaCcnE1-/- mice implicates that Cdk2 is only deleted in liver 
parenchyma cells, while CcnE1 is constitutively depleted. Therefore, in the previous 
experiments it could not be excluded that the residual cell proliferation observed in 
Cdk2ΔhepaCcnE1-/- mice after PH was performed by Cdk2 proficient cells such as 
hepatic progenitor cells (also termed oval cells) or hepatic immune cells which 
proliferated or infiltrated the liver as an immediate response towards acute surgical 
liver injury.  
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To address this very important question, the level of residual Cdk2 gene 
expression in the regenerating liver of Cdk2ΔhepaCcnE1-/- mice was determined at 
different time points after PH using a semi-quantitative rtPCR approach (Figure 3.24 
A-B). While the Cdk2 deletion efficiency in total liver of untreated Cdk2ΔhepaCcnE1-/- 
mice was approximately 95%, Cdk2 re-expression in liver of hepatectomized animals 
gradually increased until 96 h after PH. At this time point, Cdk2 deletion efficiency was 
reduced to 70%. However, 7 days after surgery, the Cdk2 deletion efficiency was 
again almost complete reflecting the level of untreated mice (Figure 3.24 B). These 
data demonstrate that liver regeneration and thus residual hepatocyte proliferation in 
Cdk2ΔhepaCcnE1-/- mice is associated with a transient repopulation of the liver with 
Cdk2-expressing cells of yet unknown identity.   
 
Figure 3.24: Transient Cdk2 re-expression in Cdk2ΔhepaCcnE1-/- liver after PH. WT and 
Cdk2ΔhepaCcnE1-/- mice were subjected to PH. At time points indicated, mRNA of liver samples 
was isolated and reverse transcribed to cDNA. (A) Semi-quantitative rtPCR for measuring 
Cdk2 deletion efficiency was performed with cDNA as template using primers locating in exon 
1 and exon 4 of the Cdk2 gene respectively. The upper band specifically indicates WT Cdk2 
gene expression while the lower band indicates a truncated Cdk2 cDNA lacking exon 2. P.H.: 
primary hepatocytes derived from Cdk2Δhepa mice were used as positive control for complete 
Cdk2 deletion. (B) Quantification of deletion efficiency. Signal intensity of WT and knock out 
bands was digitally quantified using ImageJ software (http://rsbweb.nih.gov/ij/download.html). 
Deletion efficiency was calculated as the contribution of the lower band to total signal intensity 
in percent. Each value represents an average of 3 independent liver samples. Data is 
presented as the mean ± standard deviation. 
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Two major cell populations were considered to be most likely involved in Cdk2 
re-expression in Cdk2ΔhepaCcnE1-/- mice: immune cells or liver progenitor cells.  
Immune cell infiltration is a well characterized phenomenon after PH (Dong et al. 2007) 
and in Cdk2ΔhepaCcnE1-/- mice these cells would be Cdk2 proficient. Liver progenitor 
cells could also contribute to liver regeneration. However, the precise contribution of 
oval cells for liver regeneration is still controversially discussed (Duncan et al. 2009; 
Malato et al. 2011). 
To further test the hypothesis that progenitor cells such as oval cells were 
involved in liver regeneration of Cdk2ΔhepaCcnE1-/- mice, expression of potential 
markers for progenitor cells e.g. cytokeratin 19 (CK19), Prominin/CD133, 
α-fetoprotein (AFP) and Sry (sex determining region Y)-box 9 (Sox9) was measured 
using qRT-PCR (Alison et al. 2008; Dorrell et al. 2011).  
 
Figure 3.25: Gene expression of potential markers for liver progenitor cells (A-C) Gene 
expression profile of CK19, CD133 and AFP in WT and Cdk2ΔhepaCcnE1-/- mice at 0-72 h post 
PH was determined by qPCR. (D) Gene expression profile of Sox9 in WT and 
Cdk2ΔhepaCcnE1-/- mice at 0-168 h post PH was determined by qPCR. For each group, 3-5 
animals (7-9 weeks old) were analyzed. Data is presented as the mean ± standard deviation. *: 
p<0.05; ***: p<0.001. 
0 40 48 72
0
1
2
3
4
Cdk2∆hepaCcnE1-/-
WT
*
CK19
Time after PH (h)
C
K
19
/G
AP
D
H 
m
RN
A
(fo
ld
 in
du
ct
io
n)
0 40 48 72
0
2
4
6
8
WT
Cdk2∆hepaCcnE1-/-
CD133
*
Time after PH (h)
C
D
13
3/
G
AP
D
H 
m
RN
A
(fo
ld
 in
du
ct
io
n)
0 40 48 72
0
5
10
WT
Cdk2∆hepaCcnE1-/-
AFP
*
Time after PH (h)
AF
P/
G
AP
D
H 
m
RN
A
(fo
ld
 in
du
ct
io
n)
A
C
B
D
0 40 48 72 168
0
5
10
15
WT
Cdk2∆hepaCcnE1-/-
Sox9
***
***
Time after PH (h)
So
x9
/G
AP
D
H 
m
RN
A
(fo
ld
 in
du
ct
io
n)
59 
 
 Results  
Gene expression analysis of these examined progenitor cell markers displayed a 
moderate induction of all factors in WT liver after PH (Figure 3.25 A-D) suggesting that 
activation of progenitor cells marginally contributes to normal liver regeneration. CK19 
and CD133 showed significantly higher expression in WT liver especially 48 h and 72 
h after PH (Figure 3.25 A-B). In contrast, AFP showed significantly higher expression 
in Cdk2ΔhepaCcnE1-/- liver 48 hour after PH (Figure 3.25 C). The timely overlap 
between Cdk2 re-expression and enhanced AFP induction hints at the possibility that 
an AFP-expressing cell population could contribute to liver regeneration in 
Cdk2ΔhepaCcnE1-/- liver. Interestingly, Sox9 was substantially higher expressed in 
untreated liver of Cdk2ΔhepaCcnE1-/- mice compared to WT animals (Figure 3.25 D). 
After PH, the expression level of Sox9 fluctuated slightly in WT and Cdk2ΔhepaCcnE1-/- 
liver until 72 h and was overall higher in Cdk2ΔhepaCcnE1-/- liver. Most strikingly, Sox9 
expression reached the peak value after 7 days liver reconstitution in 
Cdk2ΔhepaCcnE1-/- mice indicating a repopulation of Sox9-expressing cells, which was 
not observed at all in WT animals. These measurements provided evidence of 
progenitor cells for liver regeneration in Cdk2ΔhepaCcnE1-/- mice. However, a clear 
identification of a certain progenitor cell population will need further investigation.  
To further characterize the cell population that is still capable of proliferating in 
Cdk2ΔhepaCcnE1-/- liver, co-staining experiments were performed using Ki-67 as a 
general proliferation marker and Hepatocyte Nuclear Factor 4 alpha (HNF4α) as a 
marker for hepatocytes. Of note, it has been suggested that HNF4α might also be 
involved in differentiation of oval cells into hepatocytes and thus is not a very pure 
hepatocyte marker (Nagy et al. 1994; Li et al. 2006; Hay et al. 2008). 
 
Figure 3.26: Proliferating liver cells in Cdk2ΔhepaCcnE1-/- mice after PH are 
hepatocyte-like cells and express HNF4α. Cdk2ΔhepaCcnE1-/- mice were subjected to PH 
and then sacrificed 40 h after PH. Liver sections were co-stained with fluorescence-labelled 
antibodies directed against Ki-67 (red) and HNF4α (green). Nuclei are stained blue by DAPI. 
Co-expression of Ki-67 and HNF4α is indicated in yellow.   
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Representative staining images are shown in Figure 3.26, which clearly 
demonstrate that the vast majority of Ki-67 positive cells also express 
HNF4α implicating that proliferating cells in Cdk2ΔhepaCcnE1-/- liver after PH are mostly 
hepatocytes. 
 
3.5 Genetic dissection of the complete Cdk2/CcnE complexes in the 
liver regeneration model 
 
3.5.1 CcnE2 is dispensable for residual liver regeneration in murine liver 
lacking Cdk2 and CcnE1  
 
The previous results hint at an essential role of CcnE1 during liver regeneration if 
Cdk2 is no longer available (i.e. in Cdk2Δhepa mice). However, the obvious question 
whether and how CcnE2 (the closest homologue of CcnE1) contributes to 
compensatory liver regeneration in Cdk2Δhepa mice, was not answered so far.  
To address this problem, Cdk2ΔhepaCcnE1ΔhepaCcnE2-/- mice were generated as 
part of this study and subjected to PH. Interestingly, hepatocytes lacking the complete 
Cdk2/CcnE complex displayed substantial reduction of DNA synthesis 40 h and 48 h 
after PH, which was very similar to the observations previously described for 
Cdk2ΔhepaCcnE1-/- mice (Figure 3.27 A medium panel and Figure 3.18). These 
unexpected data demonstrates that CcnE2 does not contribute to residual hepatocyte 
proliferation in Cdk2ΔhepaCcnE1-/- mice.  
To further support this finding, Cdk2ΔhepaCcnE2-/- mice were generated and also 
tested for efficient liver regeneration. Surprisingly, combined deficiency for Cdk2 and 
CcnE2 allowed normal DNA synthesis and liver regeneration, which was not 
significantly different in comparison to WT controls (Figure 3.27 A-B). Accordingly, 
CcnE2 is not essential for normal S-phase progression in Cdk2Δhepa mice.  
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3.5.2 Concomitant ablation of both E-type cyclins mimics the phenotype 
of Cdk2∆hepaCcnE1-/- mice and substantially inhibits liver regeneration  
 
E-type cyclins were once believed to be crucial to drive cell entry into S-phase. 
Surprisingly, E-type cyclins were shown to be dispensable for a large number of cell 
types during mouse development. However, for some other cell types E-type cyclins 
are critically required. They are for example indispensable for endoreplication of 
trophoblast giant cells and megakaryocytes as well as cardiac development. 
Furthermore, E-type cyclins are absolutely essential for re-entry of murine embryonic 
fibroblasts into S-phase from quiescence induced by serum starvation (Geng et al. 
2003).  
Based on recent reports, one working hypothesis of the present study was that 
combined ablation of CcnE1 and CcnE2 in hepatocytes should completely block cell 
proliferation and subsequent liver regeneration due to inability of hepatocytes to exit 
the G0 phase. 
In order to test this hypothesis, constitutive CcnE2-/- mice were crossed with 
conditional, hepatocyte-specific CcnE1 knockout mice under control of an Alfp-Cre 
transgene to generate CcnE1ΔhepaCcnE2-/- mice. In subsequent experiments, 7-8 
weeks old CcnE1ΔhepaCcnE2-/- mice as well as matching WT controls were subjected 
to 70% partial hepatectomy. BrdU staining revealed that both livers of WT and 
CcnE1ΔhepaCcnE2-/- animals started DNA-synthesis 36 h after PH. In agreement with 
the previous experiments, WT mice reached peak of DNA-synthesis between 40-48 h 
after PH. In contrast CcnE1ΔhepaCcnE2-/- mice showed extensively inhibited 
DNA-synthesis at these time points (Figure 3.28 A-B). These data suggested that the 
onset and termination of S-phase is not affected by combined loss of both E-type 
cyclins. However, E-type cyclins are essential for efficient DNA-synthesis.  
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Figure 3.28: Ablation of CcnE1 and CcnE2 in hepatocytes substantially impairs 
DNA-synthesis of hepatocytes and liver regeneration after PH. WT and 
CcnE1ΔhepaCcnE2-/- mice were subjected to PH. Remnant livers were analyzed at 0-168 h after 
surgery. (A) Immunofluorescence staining for BrdU incorporation on liver cryosections. BrdU 
positive signals located in nuclei were stained green by ALEX 488. Nuclei were stained blue by 
DAPI. (B) Quantification of BrdU-positive hepatocytes. Data is calculated as percentage of 
BrdU-positive nuclei per magnification field. For each mouse at least 5-10 representative 
magnification fields were counted. Each value represents the mean of 5-10 mice. (C) Liver 
weight/body weight index (%) at indicated time points after PH. Data is presented as the 
average ± standard deviation. 
 
In line with these results involving reduced DNA-synthesis, CcnE1ΔhepaCcnE2-/- 
mice showed significantly impaired liver mass restoration as evidenced by a reduced 
liver mass index at 72-168 h post PH (Figure 3.28 C). Based on the fact that deletion 
of CcnE1 alone marginally impedes liver regeneration after PH, while deletion of 
CcnE2 alone even enhances liver regeneration, the present results reveal an 
overlapping function between CcnE1 and CcnE2.  
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Figure 3.29: Genetic dissection of the Cdk2/CcnE complexes identifies that combined 
depletion of CcnE1 with CcnE2 or Cdk2 blocks hepatic cell cycle. WT, Cdk2Δhepa, 
Cdk2ΔhepaCcnE1-/-, Cdk2ΔhepaCcnE2-/-, CcnE1ΔhepaCcnE2-/- and Cdk2ΔhepaCcnE1ΔhepaCcnE2-/- 
mice were subjected to PH and sacrificed 48 hours after resection. Two hours before killing, all 
mice were injected with BrdU. Immunofluorescence staining for BrdU incorporation on liver 
cryosections was performed and percentage of BrdU positive hepatocytes was quantified. 
Data is calculated as percentage of BrdU-positive nuclei per magnification field. Each value 
represents the mean of 5-10 mice. For each mouse at least 5-10 representative magnification 
fields were counted. Data is presented as the mean ± standard deviation. *: p<0.05. 
 
The key data obtained from the systematic dissection of the Cdk2/CcnE 
complexes in hepatocytes is summarized in Figure 3.29: Ablation of Cdk2 alone does 
not affect liver regeneration at all, while combined loss of Cdk2 and CcnE1 resulted in 
approximately 50% reduction of S-phase during peak interval. An almost identical 
impairment of liver regeneration was observed, when either both E-cyclins or the 
complete Cdk2/CcnE complex were abrogated, while concomitant ablation of Cdk2 
and CcnE2 had no effect.  
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4. Discussion 
 
Cell cycle progression in higher eukaryotic cells is governed by specific complex 
combinations of Cdks and their regulatory subunits cyclins. Cdk2, one of the 
interphase Cdks (referred to as Cdk4, Cdk6 and Cdk2), orchestrates several cell cycle 
events such as G1/S transition and progression via complex formation with E- and 
A-type cyclins, respectively (Morgan 1997). Previous in vitro studies demonstrated the 
importance of Cdk2 by showing a series of evidences such as expression of a 
dominant-negative Cdk2 mutant, over-expression of the Cdk2 inhibitor p27 or 
microinjection of antibodies against Cdk2, CcnE or CcnA2 arrests cell cycle and 
blocks DNA replication (Pagano et al. 1992; van den Heuvel and Harlow 1993; Polyak 
et al. 1994; Ohtsubo et al. 1995). This well accepted function of Cdk2 was challenged 
in vivo by engineering knockout mice constitutively lacking Cdk2. Surprisingly, these 
mice display overall normal embryogenesis and postnatal development (Berthet et al. 
2003; Ortega et al. 2003). Nevertheless, cell type specific functions of Cdk2 in 
different organs remain still incompletely understood (Berthet and Kaldis 2007). The 
initial aim of the current work was to examine how far Cdk2 plays a role in liver 
regeneration and to further investigate the compensatory mechanisms that allow 
proper liver regeneration in absence of Cdk2 by using the well-established model of 
partial hepatectomy (PH). This effort was combined with the ultimate aim to 
substantially block hepatocyte proliferation by inhibiting combinations of Cdk2 and 
associated cyclins. For this purpose hepatocyte specific Cdk2 conditional knock-out 
mice were generated by taking advantage of the albumin-Cre/loxP system. Based on 
data from this mouse model, a crucial kinase-independent role of CcnE1 - but not of 
CcnE2 - in liver regeneration of Cdk2∆hepa mice was postulated. To test this hypothesis, 
Cdk2∆hepa mice were crossed with CcnE1-/- mice to generate Cdk2∆hepaCcnE1-/- double 
knockout mice. These animals revealed a deficiency in DNA replication during liver 
regeneration associated with a defect in MCM loading and repression of CcnA2 
expression. Furthermore, genetic dissection of the complete Cdk2/CcnE complex was 
conducted by comparing hepatocyte proliferation after PH in mouse mutants 
harbouring all possible combinations of CcnE1, CcnE2 and Cdk2 knockout alleles. It 
was shown that only combined depletion of CcnE1 either with CcnE2 or Cdk2 could 
extensively block DNA synthesis of hepatocytes after PH indicating CcnE1 as a most 
important subunit of Cdk2/CcnE complexes. The physiological consequences, 
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underlying compensatory mechanisms and clinical relevance of different knockout 
mouse models will be discussed below.  
 
4.1 Cdk2 activity is dispensable for liver regeneration 
 
Liver regeneration is an important process for the homeostasis of the normal liver, 
but also for recovery of liver functions in response to liver injury. However, 
de-regulated or continuous liver regeneration is also involved in development of liver 
diseases like hepatocellular carcinoma (HCC) and liver fibrosis (Michalopoulos and 
DeFrances 1997; Fausto 2001; Michalopoulos 2010). Liver regeneration following 2/3 
partial hepatectomy in mice has become a useful model to investigate hepatocyte 
proliferation in vivo. Since the most established functions of Cdk2/cyclin complexes 
are related to events in G1/S transition and S-phase progression, the current study 
concentrated on one of the most important stages of liver regeneration, DNA 
replication, with a special focus on G1/S-phase transition and S-phase progression.   
The analysis of cell cycle regulation in Cdk2∆hepa mice revealed that hepatocyte 
specific deletion of Cdk2 does not affect G1/S transition and S-phase progression 
after PH at all. After 1 week recovery, liver mass of Cdk2∆hepa mice was restored to the 
same extent as observed in WT animals. This result is in agreement with a present 
study using constitutive Cdk2 knockout mice, which also did not reveal significant 
differences in hepatic S-phase progression after PH between WT and knockout 
animals (Satyanarayana et al. 2008b). However, another study revealed conflicting 
results, which showed a strongly reduced percentage of BrdU positive liver cells 
exactly 42 h after PH in Cdk2 knockout mice (Hanse et al. 2009). Given that both 
groups used the same Cdk2 knockout mouse strain these contradictory results cannot 
be explained without knowledge of further experimental details. Nevertheless, the 
present data clearly support the finding of Satyanarayana et al. that Cdk2 is 
dispensable for liver regeneration after PH.   
 
4.1.1 Identification of potential compensatory kinase activities in 
Cdk2-deficient liver 
 
In WT cells, Cdk2 forms kinase complexes with CcnE (i.e. CcnE1 and/or CcnE2) 
in late G1-phase and completes phosphorylation of Rb together with Cdk4/CcnD and 
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Cdk6/CcnD complexes (Lundberg and Weinberg 1998). Though Cdk4/6/CcnD and 
Cdk2/CcnE complexes share the task to phosphorylate Rb, there are spatial and 
temporal differences of phosphorylation between two kinase complexes in WT cells. 
Temporally, Cdk4/6/CcnD phosphorylates Rb in early G1-phase, while Cdk2/CcnE 
continues phosphorylation in late G1-phase. Regarding Rb phosphorylation sites, 
Cdk4/6/CcnD and Cdk2/CcnE complexes show different preferences (Kitagawa et al. 
1996; Zarkowska and Mittnacht 1997). It has been postulated that this specificity 
provided by different kinase complexes temporally regulates Rb phosphorylation 
(Knudsen and Knudsen 2006). 
Following PH, Rb was phosphorylated in Cdk2∆hepa mice to the same extent 36 h 
and 48 h after surgery as observed in WT mice. At 36 h post-surgery, an elevated 
CcnD1-related kinase activity was present in Cdk2∆hepa liver suggesting that 
Cdk4/CcnD1 and/or Cdk6/CcnD1 might compensate for Cdk2-deficiency at this time 
point. Mice deficient for both Cdk2 and Cdk4 show normal liver regeneration (Barriere 
et al. 2007). Therefore it is likely that Cdk6 rather than Cdk4 may take over the 
function of Cdk2 at early regeneration stages after PH. In line with this hypothesis are 
findings where simultaneous inhibition of Cdk4/Cdk6 using the novel inhibitor 
Pyridopyrimidine (PD-0332991) blocked hepatocyte proliferation and induced G1/S 
phase cell cycle arrest in regenerating liver, which also suggests an important function 
of Cdk6 for liver regeneration (Rivadeneira et al. 2010).  
Cdk1 is the only mitotic kinase responsible for cell division in mammalian cells. 
An augmented kinase activity of the Cdk1 complex was detected at 48 h after PH in 
Cdk2∆hepa liver suggesting a compensatory function of Cdk1 for the loss of Cdk2 
during S-phase progression. In support of this finding, Aleem and colleagues 
demonstrated in their study that Cdk1 regulates the G1/S phase transition in several 
tissues (spleen and thymus) of p27-/-Cdk2-/- mice. In this study, the compensatory 
Cdk1 activity was mediated by CcnE1-Cdk1 interaction in their model (Aleem et al. 
2005). However, in the present study the elevated Cdk1 activity in regenerating 
Cdk2∆hepa liver was not mediated by CcnE, but presumably by CcnA2. Surprisingly, a 
non-canonical kinase activity of both E-type cyclins with alternative Cdks could not be 
detected at all. This is likely attributed to the presence of p27, which associates with 
CcnE and reduces its activity (Berthet et al. 2003; Ortega et al. 2003; Aleem et al. 
2005). Another study from Satyanarayana at el. also emphasizes the role of Cdk1 to 
compensate the loss of Cdk2 via premature translocation to the nucleus in Cdk2 
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deficient murine embryonic fibroblasts (MEFs). However, in their study the authors did 
not address the question which cyclin guides the trafficking of Cdk1 into the nucleus. 
Of note, Cdk1 does not contain a nuclear localization sequence (NLS) and thus can 
only translocate into the nucleus in association with an NLS-containing cyclin (Moore 
et al. 1999). So far it is not known if the same mechanism also applies for the 
proliferating liver. In the present experimental setting, a premature activation of Cdk1 
was not observed and an earlier expression of the Cdk1 activator CcnA2 was also not 
detected in Cdk2∆hepa liver after PH. It is therefore suggested that Cdk2 deficiency is 
not compensated by premature Cdk1 translocation during liver regeneration. However, 
this conclusion does not exclude the possibility that the remaining Cdk1 activity is still 
sufficient to drive cell cycle progression in the liver as it was already shown in 
embryonic fibroblasts lacking all interphase Cdks (Cdk2, Cdk4 and Cdk6) 
(Santamaria et al. 2007).  
In S-phase progression both Cdk2/CcnA2 and Cdk1/CcnA2 contribute to 
regulation of the DNA replication machinery (Yam et al. 2002). Current work implies 
that in the absence of Cdk2 more CcnA2 molecules are available for binding to Cdk1 
and further enhance Cdk1 activity. The fact that administration of the Cdk1/2 inhibitor 
Roscovitine strongly reduced the DNA synthesis after PH in both WT and Cdk2∆hepa 
mice confirms this hypothesis. Consistent with the present results, a recent study 
using hepatocyte-specific Cdk1 knockout mice interestingly showed that livers lacking 
Cdk1 have an elevated Cdk2/CcnA2 activity due to enhanced binding of CcnA2 with 
Cdk2, which is responsible for aberrant DNA re-replication in these mice (Diril et al. 
2012). Unexpectedly, the same study also revealed that despite a defect of cell 
division in Cdk1-deficient liver, liver regeneration was not impaired suggesting that 
liver regeneration can alternatively be driven by cell growth without cell division.  
Taken together, the present results strongly imply that a widespread redundancy 
exists between interphase Cdks during liver regeneration. Multiple combinations of 
Cdk/cyclin complexes (at least CcnD1-related kinase and Cdk1/CcnA2) contribute to 
G1/S transition and S-phase progression in absence of Cdk2. Especially Cdk1 has a 
high compensatory potential to overcome the loss of interphase Cdks, which is 
strongly supported by the Roscovitine experiments (see chapter 3.2.1), where the 
Roscovitine treatment after PH extensively inhibited hepatocyte proliferation in both 
WT and Cdk2∆hepa mice.  
Besides Rb, Cdk2 has several other targets including proteins involved in 
centrosome duplication such as nucleophosmin, proteins essential for origin firing 
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such as Cdc6 and Cdc45, histone biosynthesis such as p220NPAT, DNA replication, its 
own activator CcnE and its own inhibitor p27Kip1 (Hwang and Clurman 2005). One 
recent study demonstrated that hepatocytes lacking Cdk2 have normal centrosome 
content and normal centrosome duplication after PH (Hanse et al. 2009). Further 
investigation is required to identify compensatory mechanisms for phosphorylation of 
other prototypical substrates in absence of Cdk2. 
 
4.1.2 CcnE1 contributes to compensatory proliferation of Cdk2-deficient 
hepatocytes in a kinase-independent manner 
 
E-type cyclins (CcnE1 and CcnE2) are considered regulatory subunits of Cdk2 
(Morgan 1997). Cyclin E gene expression is tightly modulated in an E2F-mediated 
manner during cell cycle progression (Le Cam et al. 1999). Transient induction of 
E-type cyclins in late G1-phase is assumed to provide a threshold for entry into the 
S-phase (Krude et al. 1997; Geng et al. 2003). Although both CcnE1 and CcnE2 
share high structural similarity and are co-expressed in all proliferating cells, CcnE1 
has a higher Cdk2 activating capacity than CcnE2 (Lauper et al. 1998; Gudas et al. 
1999; Geng et al. 2001). Previous studies from our lab demonstrated that genetic 
ablation of CcnE2 induces over-expression of CcnE1, which in turn results in 
accelerated and sustained DNA synthesis after PH due to prolonged Cdk2 activity. 
After 1 week liver recovery, 45% greater liver mass was observed in CcnE2-/- mice 
compared with WT animals (Nevzorova et al. 2009). More recently, another study 
from our lab provides evidence that CcnE1 but not CcnE2 plays a critical role for 
activation, proliferation and survival of hepatic stellate cells (Nevzorova et al. 2012). 
Though CcnE1-/- mice did not show any abnormality of liver regeneration except slight 
delay in S-phase entry after PH, all these evidences point to a more important role of 
CcnE1 rather than CcnE2 favoring cell survival and proliferation. 
Several studies demonstrated that under some circumstances Cdk1 can 
substitute Cdk2 to form kinase active complexes with CcnE such as in absence of 
both p27 and Cdk2 or in absence of all interphase Cdks (Aleem et al. 2005; 
Santamaria et al. 2007). However, current data clearly evidenced that these findings 
must be cell type specific and do not apply for Cdk2-deficient hepatocytes in vivo for 
two reasons: First, any relevant Cdk1-related kinase activity was not detected at the 
expression peak of E-type cyclins (36 h post PH). Second, both CcnE1 and CcnE2 
related kinase activities were not detected at all investigated time points after PH in 
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Cdk2∆hepa mice. Nevertheless, a higher basal expression level of CcnD1 as well as an 
earlier expression of CcnE1, but not of CcnE2, was observed in Cdk2∆hepa liver after 
PH. It is therefore speculated that in WT cells a feedback control between activation of 
Cdk2 and expression of CcnD1 and CcnE1 exists, explaining aberrant expression of 
these cyclins after loss of Cdk2, which potentially contributes to compensatory effects 
in a Cdk2-independent manner. 
A recent study supporting this hypothesis demonstrated that CcnE1 is loaded 
onto chromatin of quiescent embryonic fibroblasts in a Cdk2-independent manner, 
where it facilitates MCM loading during assembly of pre-replication complex via 
physical interaction with Cdt1 (Geng et al. 2007). This kinase-independent function of 
E-type cyclins seems to be essential for entering S-phase from quiescence (Geng et 
al. 2003). Quiescent murine embryonic fibroblasts lacking both E-type cyclins 
therefore fail to re-enter the cell cycle.  
To exploit the kinase-independent functions of CcnE1 for proliferation in 
Cdk2-deficient liver, an in vitro model using mitogenic stimulated primary Cdk2-/- 
hepatocytes was employed. In good agreement with the data from the liver 
regeneration model, an accelerated induction of CcnE1 was also observed in vitro, 
which was associated with an improved loading of MCM2 on chromatin. A similar 
phenomenon was observed in another in vitro study, where Cdk2 was inhibited by 
aminothiazole compound 25, which led to an increase in binding of the MCM helicase 
onto chromatin during S-phase (Zhu et al. 2004). This increased loading of MCM2 
onto chromatin in the absence of Cdk2 may favor DNA replication of hepatocytes to 
compensate the disadvantage caused by the loss of Cdk2 in other cell cycle events. 
This hypothesis was fully supported by experimental data in the present study 
demonstrating that Roscovitine induced cell cycle arrest of primary hepatocytes can 
be partially rescued by adenoviral over-expression of CcnE1 (see chapter 3.2.2). 
Taken together, the present data obtained so far consider CcnE1 as an important or 
even essential proliferation factor in absence of Cdk2. It was postulated that in this 
case mice lacking both Cdk2 and CcnE1 should have a more severe phenotype. 
To ultimately proof the hypothesis that non-canonical functions of CcnE1 are 
indispensible for proliferation of Cdk2-deficient hepatocytes, Cdk2∆hepaCcnE1-/- mice 
were generated. In vitro experiments clearly demonstrated that hepatocytes with 
combined deletion of Cdk2 and CcnE1 have severely impaired viability in cell culture 
by displaying dramatically diminished cell proliferation and reduced cell number due 
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to cell death. In accordance with these findings, Cdk2∆hepaCcnE1-/- liver also showed 
impaired liver regeneration and significantly reduced liver weight / body weight ratio in 
vivo after PH. Of notice, under in vivo conditions excessive cell death (as seen in 
primary hepatocytes) and enhanced liver injury after PH were not observed after 
concomitant depletion of both Cdk2 and CcnE1. The improved cell viability of 
Cdk2/CcnE1 knock out hepatocytes in liver may be explained by a protective tissue 
environment provided through the complex liver structure including immune cells and 
their production of protective cytokines and mitogens, which cannot be exactly 
reproduced in a cell culture model (Michalopoulos 1990; Mitaka 1998; Groneberg et al. 
2002; Boess et al. 2003). Alternatively, it could be speculated that hepatic progenitor 
cells, which do not express albumin at this stage and therefore still harbor the cdk2 
gene, differentiate into mature hepatocytes and contribute to restoration of liver mass 
if Cdk2-/-CcnE1-/- hepatocytes are unable to proliferate. This speculation is supported 
by two results of the current study: First, it was demonstrated that Cdk2 is 
re-expressed in Cdk2∆hepa liver after PH. The timing of this re-expression (36-96 h post 
PH) is not completely overlapping with the particular time of immune cell infiltration 
(Fausto 2006; Dong et al. 2007), pointing to the possibility that indeed a population of 
Cdk2-proficient stem cells contributes to liver regeneration in Cdk2∆hepaCcnE1-/- mice. 
Second, expression of the fetal hepatocyte marker alpha-fetoprotein (AFP) is 
significantly higher in Cdk2∆hepaCcnE1-/- liver at the maximum of proliferation (48 h post 
PH) again hinting at a AFP-positive and thus less differentiated hepatic cell population, 
which preferentially engrafts the liver in absence of both Cdk2 and CcnE1. It is 
concluded that after differentiation of these cells into true hepatocytes, they would 
start expressing albumin - and thus cre - and consequently induce cre-dependent 
deletion of the cdk2 gene. This prediction would perfectly match the observed kinetics 
of Cdk2 re-expression and ablation during liver regeneration. However, to definitely 
prove that progenitor cells are involved in liver regeneration of Cdk2∆hepaCcnE1-/- mice, 
further investigation is required which was beyond the scope of this study.  
Besides expansion of hepatocytes via marginal cell division of mature cells (and 
potentially progenitor cell derived hepatocytes), it was demonstrated that hypertrophic 
cell growth of hepatocytes also contributed to liver regeneration in Cdk2∆hepaCcnE1-/- 
mice. This seems to be a common mechanism in liver with cell cycle defects as a 
recent study using hepatocyte-specific Cdk1 knockout mice revealed that hepatocytes 
lacking Cdk1 cannot undergo mitosis but show normal liver regeneration via 
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hypertrophic growth (Diril et al. 2012). However, the underlying mechanisms 
responsible for liver hypertrophy are poorly understood so far. Decrypting pathways 
regulating liver hypertrophy will be of high importance to fully understand liver 
regeneration.  
The DNA-replication defect of Cdk2∆hepaCcnE1-/- hepatocytes, which was 
observed both in vivo and in vitro models, can be explained by two factors: strong 
reduction of MCM loading onto chromatin and low expression of CcnA2 and CcnA2 
related kinase activity. The kinetics of pre-RC formation and MCM loading is different 
in continuously cycling cells (embryonic stem cells, immortal cell lines) compared to 
usually quiescent cells, such as hepatocytes. During continuous cell cycling, MCM 
proteins are detectable throughout the cell cycle and binding of MCM to the replication 
origins occurs immediately after the exit from mitosis (Mendez and Stillman 2000). 
Accordingly, Cdk2/CcnE is not necessary for pre-RC formation of continuously 
proliferating cells (Geng et al. 2003; Geng et al. 2007). In contrast, the present data 
revealed that MCM2 expression is not detectable in quiescent hepatocytes but 
induced upon mitogenic stimulation. Cdk2 deficient hepatocytes harbour stronger 
CcnE1 expression compared to WT cells, which may direct MCM and Cdt1 to 
chromatin in a Cdk2-independent manner potentially facilitating G1/S-phase transition. 
Consequently, an additional depletion of CcnE1 in Cdk2∆hepa hepatocytes breaks 
down this compensatory advantage and leads to the defect in cell proliferation.  
Another important factor, which also accounts for impaired DNA replication of 
Cdk2∆hepaCcnE1-/- hepatocytes, is repression of CcnA2 expression. CcnA2 is essential 
for regulation and progression through S-phase in virtually all cell types (Chibazakura 
et al. ; Girard et al. 1991; Erlandsson et al. 2000; Kalaszczynska et al. 2009). During 
cell cycle progression, CcnA2 gene expression is preceded by activation of E-type 
cyclins in most if not all cases, at the beginning of S-phase, and expressed throughout 
S- and G2-phase. Once induced, CcnA2 activates Cdk2 and Cdk1 via complex 
formation, thereby driving S-phase progression (Yam et al. 2002; Hochegger et al. 
2008). In vitro studies demonstrated that inhibition of CcnA2 blocked DNA-synthesis 
as well as G2/M entry (Girard et al. 1991; Zerfass-Thome et al. 1997; Erlandsson et al. 
2000). In vivo, CcnA2 knockout mouse embryos died shortly after implantation 
(Kalaszczynska et al. 2009).   
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Figure 4.1: Model explaining the phenotype of Cdk2 or CcnE1 knockout mice and 
Cdk2∆hepaCcnE1-/- double knockout mice in the liver. Left side: Deletion of Cdk2 alone does not 
affect hepatocyte proliferation. Cdk4/6/CcnD1 and Cdk1/CcnA2 activity compensate the loss 
of Cdk2 activity at early (36 h) and later (48 h) time points after PH, respectively. In addition, 
accelerated induction of CcnE1 enhances Cdk2-independent MCM loading onto chromatin. 
Right side: Deletion of CcnE1 alone marginally delays S-phase entry of hepatocytes after PH. 
However, liver regeneration is not impaired. Loss of Cdk2/CcnE1 activity is compensated by 
Cdk2/CcnA2 activity. Bottom: An additional depletion of CcnE1 in Cdk2∆hepa mice abolishes 
MCM loading, while an additional deletion of Cdk2 in CcnE1-/- mice abrogates the 
compensatory Cdk2/CcnA2 activity. Altogether, deficiencies in MCM loading and Cdk2/CcnA2 
activity reduce DNA-synthesis of hepatocytes and lead to inefficient liver regeneration.    
 
From present data together with previous findings from our lab it is concluded 
that CcnA2 fulfills essential compensatory functions via complex formation with Cdk1 
in Cdk2∆hepa mice and with Cdk2 in CcnE1-/- mice, respectively (Figure 4.1). 
Furthermore, the present data showed that Cdk2∆hepaCcnE1-/- hepatocytes displayed 
normal CcnD1 expression level but dramatically reduced CcnA2 expression 
compared to WT cells. Since Cdk2 or CcnE1 single knockout hepatocytes showed 
normal expression of CcnA2, it seems that Cdk2 and CcnE1 independently regulate 
transactivation of CcnA2 gene expression. Therefore only combined deletion of both 
Cdk2 and CcnE1 is sufficient to abrogate CcnA2 gene expression. This idea is in part 
supported by a previous report, which indicates that Cdk2 and CcnE1 are both 
required for transcriptional activation of the CcnA2 promoter. Binding of CcnE alone to 
the CcnA2 promoter is not sufficient for CcnA2 transcription, since a kinase-negative 
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mutant of Cdk2 abrogates promoter activation of CcnA2 (Schulze et al. 1995; 
Zerfass-Thome et al. 1997). Accordingly, either Cdk2 kinase activity or CcnE1 is 
required to initiate CcnA2 expression. In turn, CcnA is absolutely essential for 
proliferation of embryonic stem cells and hematopoietic cells, while in MEFs E- and 
A-type cyclins share high functional redundancy. MEFs lacking either E- or A-type 
cyclins showed normal G1/S transition and S-phase progression, whereas cell cycle 
was completely extinguished in cells lacking both CcnE and CcnA (Kalaszczynska et 
al. 2009). It is concluded that Cdk2∆hepaCcnE1-/- hepatocytes reflect a similar scenario 
as these cells additionally lack CcnA2 therefore leading to inhibited DNA-replication.   
 
4.2 Genetic dissection of the complete Cdk2/CcnE complexes 
identifies CcnE1 as the most important component for S-phase 
transition 
 
To fully understand the role of the Cdk2/CcnE complexes for liver regeneration, 
all subunits (Cdk2, CcnE1 and CcnE2) were simultaneously deleted in hepatocytes 
using a genetic approach. Unexpectedly, these mice did not show any developmental 
abnormality and all survived 70% partial hepatectomy. After PH 
Cdk2∆hepaCcnE1∆hepaCcnE2-/- mice showed a similar defect in DNA-synthesis as 
observed in Cdk2∆hepaCcnE1-/- mice indicating that CcnE2 is not contributing to 
residual liver regeneration at all in Cdk2∆hepaCcnE1-/- mice. This key finding was further 
confirmed by analyzing Cdk2∆hepaCcnE2-/- mice. In fact these animals displayed full 
capability of DNA-synthesis after PH identical to WT animals again pointing to a 
non-essential role of CcnE2 in Cdk2∆hepa mice.  
However, CcnE2 is highly important for liver regeneration in absence of CcnE1, 
since CcnE1∆hepaCcnE2 mice showed severely impaired liver regeneration after PH, 
which was not the case for CcnE1-/- mice (Nevzorova et al. 2009). This result is in 
good agreement with earlier in vitro studies using CcnE1-/-CcnE2-/- MEFs. Combined 
genetic ablation of both CcnE1 and CcnE2 completely blocked re-entry of serum 
starved quiescent MEFs into S-phase (Berthet et al. 2003; Geng et al. 2003; Geng et 
al. 2007). Unexpectedly, though DNA replication after PH in CcnE1∆hepaCcnE2-/- mice 
was inhibited by approximately 50% compared to WT animals, a sub-population of 
hepatocytes lacking CcnE1 and CcnE2 could still re-enter S-phase and proliferate. 
The possible explanations for these findings have already been discussed in the 
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context of liver regeneration in Cdk2∆hepaCcnE1-/- mice (see above) and imply (i) 
activation of progenitor cells or (ii) partial functional compensation by alternate cyclins 
such as CcnA2.  
In fact previous work provided evidence that CcnA2 can compensate for the loss 
of E-type cyclins in a kinase-dependent manner (Kalaszczynska et al. 2009). It is thus 
highly possible that CcnA2 can also compensate kinase-independent functions of 
E-type cyclins e.g. facilitate MCM loading. A rescue experiment using over-expression 
of CcnA2 in CcnE1∆hepaCcnE2-/- hepatocytes in the future could be helpful to prove this 
hypothesis.  
Taken together, genetic dissection of the Cdk2/CcnE complexes identifies CcnE1 
as the most important kinase subunit for efficient hepatocyte proliferation. In support 
of this idea, several lines of evidence shows that CcnE1 plays an important role for 
carcinogenesis as it is frequently deregulated in many human cancers including 
hepatocellular carcinoma (Keyomarsi and Herliczek 1997; Spruck et al. 1999; 
Zschemisch et al. 2006).  
Thus, the present study provides a novel therapeutical view to inhibit proliferation 
of cancer cells by inhibiting CcnE1 together with Cdk2 or both E-type cyclins. The 
inhibition of Cdk2 alone might not be sufficient to block cell proliferation of certain 
cancer cells. The current approaches to develop small molecule Cdk-inhibitors might 
be of limited benefit especially for treating cancer with high expression of CcnE1.  
In summary, the present study largely improves the understanding of redundant 
cell cycle mechanisms in vertebrates and identifies for the first time the minimal 
requirements necessary for substantial inhibition of DNA synthesis in the liver. 
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6. Summary 
 
Complexes of Cdk2 with E-type cyclins (CcnE1 and CcnE2) specifically regulate 
the onset of DNA replication in previously quiescent mammalian cells. Partial 2/3 
hepatectomy (PH) in rodents is an established model to study this process in vivo as 
quiescent hepatocytes synchronously undergo 1-2 cell cycles after surgery.    
Surprisingly, previous studies from our lab demonstrated that unique depletion of 
CcnE1 or CcnE2 did not markedly impair hepatocyte proliferation after PH. Thus the 
initial aim of the present study was to characterize the role of Cdk2 for the hepatic cell 
cycle. As these analyses revealed that Cdk2 is also fully dispensable for cell cycle 
progression in hepatocytes, the underlying compensatory mechanisms were 
evaluated by detailed genetic dissection of the complete Cdk2/CcnE complexes with 
the ultimate aim to inhibit the hepatic cell cycle by blocking appropriate combinations 
of Cdk2 and E-cyclins.  
Hepatocyte-specific ablation of Cdk2 (Cdk2∆hepa) resulted in accelerated induction 
and overall stronger expression of CcnE1 after PH. Elevated CcnE1 levels did not 
contribute to a non-canonical kinase activity but instead performed a 
kinase-independent function by facilitating the loading of minichromosome 
maintenance (MCM) proteins on chromatin. Accordingly, hepatocytes lacking both 
Cdk2 and CcnE1 showed severely impaired loading of MCM and were unable to 
activate the S-phase mediator CcnA2 which is a prerequisite for S-phase progression. 
As a consequence, mitogen-primed Cdk2-/-CcnE1-/- hepatocytes displayed severely 
impaired cell viability and dramatically reduced proliferative capability. In vivo, DNA 
replication and subsequent liver mass reconstitution following PH were substantially – 
but not completely blocked in Cdk2∆hepaCcnE1-/- mice. Surprisingly, hepatocytes 
lacking Cdk2 and both E-cyclins did not show further impaired liver regeneration 
suggesting a negligible role of CcnE2 for cell cycle progression. In fact, 
Cdk2∆hepaCcnE2-/- mice showed normal S-phase and liver regeneration. However, 
mice lacking both E-type cyclins exhibited strongly impaired liver regeneration 
pointing to some functional overlap of CcnE1 and CcnE2.  
In summary, the current study identifies for the first time combinations of Cdk2 
and/or E-cyclins, which are largely essential for driving the hepatic cell cycle. This 
contributes to a better understanding of redundant mechanisms in the mammalian cell 
cycle machinery and may help to inhibit pathological liver cell proliferation e.g. in 
hepatocellular carcinoma.
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7. Zusammenfassung 
Komplexe von Cdk2 mit E-Cyclinen (CcnE1 und CcnE2) steuern den Übergang von 
ruhenden Säugerzellen in die S-Phase des Zellzyklus. Partielle 2/3 Hepatektomie (PH) 
in Nagern ist ein etabliertes Model, um diesen Prozess in vivo zu untersuchen. Nach 
PH durchlaufen ruhende Hepatozyten sehr synchron 1-2 Zellzyklen. Vorarbeiten 
zeigten, dass die alleinige Inaktivierung von CcnE1 oder CcnE2 nicht ausreicht, um 
die Leberregeneration nach PH maßgeblich zu blockieren. Erstes Ziel der Arbeit war 
es, die Funktion von Cdk2 für den Zellzyklus des Hepatozyten zu charakterisieren. Da 
diese Analysen frühzeitig zeigten, dass Cdk2 für den Zellzyklus von Hepatozyten 
nicht benötigt wird, sollten weiterhin die zugrunde liegenden kompensatorischen 
Mechanismen identifiziert werden mit dem Ziel, durch kombinierte Deletion von Cdk2 
und E-Cyclinen den Zellzyklus von Hepatozyten zu hemmen. 
Hepatozyten-spezifische Deletion von Cdk2 (Cdk2∆hepa) führte zu einer 
beschleunigten Induktion und erhöhten Expression von CcnE1 nach PH. Dies be-
wirkte jedoch keine zusätzliche Kinaseaktivität, sondern förderte Kinase-unabhängig 
das Beladen von Replikationsursprüngen mit dem Minichromosome Maintenance 
Complex (MCM). Dementsprechend konnten Hepatozyten mit gleichzeitigem Verlust 
von Cdk2 und CcnE1 MCM-Komplexe nicht mehr effektiv auf Chromatin laden. 
Zusätzlich war in diesen Hepatozyten die Aktivierung des S-Phase Mediators CcnA2 
fast vollständig inhibiert. Als Folge zeigten Mitogen-induzierte Cdk2-/-CcnE1-/- 
Hepatozyten ein deutlich vermindertes Überleben und eine erheblich reduzierte 
DNA-Synthese und Proliferation. In vivo war in Cdk2∆hepaCcnE1-/- Mäusen die 
DNA-Synthese sowie die Lebermassenrekonstitution nach PH ebenfalls stark inhibiert. 
Überraschenderweise bewirkte eine zusätzliche Deletion von CcnE2 in diesen Tieren 
keine weitere Beeinträchtigung der Hepatozytenproliferation. Daher scheint CcnE2 
nur eine geringfügige Bedeutung bei der Leberregeneration zu besitzen. Trotzdem 
besitzen CcnE1 und CcnE2 eine partielle funktionelle Redundanz, da 
CcnE1∆hepaCcnE2-/- Mäuse ebenfalls eine erheblich verschlechterte Leberregenera-
tion zeigten.  
Zusammenfassend identifiziert die vorliegende Arbeit erstmalig Bedingungen, unter 
denen Cdk2 oder CcnE1 für die Zellzyklusregulation in der Leber essentiell sind. 
Diese Ergebnisse tragen zu einem deutlich verbesserten Verständnis der redun-
danten Zellzyklus-Mechanismen in Säugern bei und könnten helfen, die pathologi-
sche Leberzellproliferation z.B. beim Hepatozellulären Karzinom, zu hemmen. 
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